Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentGolgi lumen

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 AGRN MUC6 MUC20

1.87e-071091639GO:0005796
GeneOntologyCellularComponentScrib-APC-beta-catenin complex

APC SCRIB

1.80e-0431632GO:0034750
GeneOntologyCellularComponentchromatin

TBX3 RARB MYT1 ESRRG CHD8 ICE1 XPC SRCAP RFX7 KLF4 INO80D SIRT1 STAT4 ZBTB37 FOXB1 TOX4 BRD8 IGFBP3 NFATC1 NFE2L2 NFIX HEY2 ELF2 PAX3 ZHX1

2.04e-04148016325GO:0000785
GeneOntologyCellularComponentaxonal growth cone

APC DCC TRAK1 AGRN

4.14e-04451634GO:0044295
HumanPhenoAbnormal nasal tip morphology

FRAS1 RARB APC MPDZ HUWE1 SRCAP RFX7 COL18A1 SETBP1 PAX3 MBD5 SRRM2 SPEN KDM6A PHIP

2.28e-063865015HP:0000436
HumanPhenoPolyphagia

CHD8 RFX7 ALMS1 MBD5 SRRM2 SPEN HTT

8.85e-0678507HP:0002591
HumanPhenoAbnormal eating behavior

CHD8 RFX7 ALMS1 MBD5 SRRM2 SPEN AGRN HTT

2.82e-05128508HP:0100738
DomainSEA

IMPG1 MUC16 MUC12 MUC13 MUC3A AGRN

2.66e-08231556PS50024
DomainSEA_dom

IMPG1 MUC16 MUC12 MUC13 MUC3A AGRN

2.66e-08231556IPR000082
DomainSEA

IMPG1 MUC16 MUC13 MUC3A AGRN

6.95e-08141555SM00200
DomainSEA

IMPG1 MUC16 MUC12 MUC13 AGRN

8.67e-07221555PF01390
DomainMARK/par1

MARK1 MARK3 MARK2

2.23e-0641553IPR033624
DomainKA1

MARK1 MARK3 MARK2

5.54e-0651553PF02149
DomainKA1_dom

MARK1 MARK3 MARK2

5.54e-0651553IPR001772
DomainKA1

MARK1 MARK3 MARK2

5.54e-0651553PS50032
Domain-

MARK1 MARK3 MARK2

5.54e-06515533.30.310.80
DomainKA1/Ssp2_C

MARK1 MARK3 MARK2

1.91e-0571553IPR028375
DomainUBA

MARK1 MARK3 HUWE1 MARK2

1.06e-04301554SM00165
DomainPDZ

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

1.77e-041411557PF00595
DomainUBA

MARK1 MARK3 HUWE1 MARK2

2.19e-04361554PF00627
Domain-

IMPG1 MUC16 AGRN

2.37e-041515533.30.70.960
DomainPDZ

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

2.38e-041481557SM00228
Domain-

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

2.58e-0415015572.30.42.10
DomainPDZ

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

2.69e-041511557PS50106
DomainPDZ

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

2.80e-041521557IPR001478
DomainVWF_type-D

MUC5B MUC4 MUC6

2.90e-04161553IPR001846
DomainVWFD

MUC5B MUC4 MUC6

2.90e-04161553PS51233
DomainVWD

MUC5B MUC4 MUC6

2.90e-04161553SM00216
DomainVWD

MUC5B MUC4 MUC6

2.90e-04161553PF00094
DomainGrowth_fac_rcpt_

EPHB3 FRAS1 CD248 MUC13 LDLR IGFBP3 EPHA2

3.28e-041561557IPR009030
DomainRetinoic_acid_rcpt

RARB ESRRG

4.06e-0441552IPR003078
DomainPROTEIN_KINASE_ATP

EPHB3 MARK1 MARK3 IRAK2 AATK MAST4 EPHA2 PEAK1 MARK2 MERTK MAP2K5 MAP3K2

4.58e-0445915512PS00107
DomainUBA

MARK1 MARK3 HUWE1 MARK2

4.78e-04441554IPR015940
DomainVWC_out

FRAS1 MUC5B MUC6

4.93e-04191553SM00215
DomainUBA

MARK1 MARK3 HUWE1 MARK2

6.17e-04471554PS50030
DomainProt_kinase_dom

EPHB3 MARK1 MARK3 IRAK2 AATK MAST4 EPHA2 PEAK1 MARK2 MERTK MAP2K5 MAP3K2

7.99e-0448915512IPR000719
DomainPROTEIN_KINASE_DOM

EPHB3 MARK1 MARK3 IRAK2 AATK MAST4 EPHA2 PEAK1 MARK2 MERTK MAP2K5 MAP3K2

8.57e-0449315512PS50011
DomainEGF-like_dom

FRAS1 IMPG1 CD248 MUC13 LDLR MUC3A MUC4 AGRN

1.14e-032491558IPR000742
DomainPROTEIN_KINASE_TYR

EPHB3 AATK EPHA2 PEAK1 MERTK

1.29e-03971555PS00109
DomainTyr_kinase_AS

EPHB3 AATK EPHA2 PEAK1 MERTK

1.29e-03971555IPR008266
DomainEGF-like_CS

CD248 MUC12 MUC13 LDLR EPHA2 MUC3A MUC4 AGRN

1.54e-032611558IPR013032
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

1.30e-13161108M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

2.43e-13171108M27412
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

4.72e-12231108M556
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

1.48e-11261108M27483
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

MUC16 MUC5B MUC12 MUC13 SPON2 MUC3A MUC4 MUC6 MUC20

2.58e-09681109M27303
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC5B MUC13 MUC4 MUC6 MUC20

9.71e-09211106MM15706
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

2.53e-08621108M546
PathwayREACTOME_DISEASES_OF_GLYCOSYLATION

MUC16 MUC5B MUC12 MUC13 SPON2 MUC3A MUC4 AGRN MUC6 MUC20

1.66e-0714311010M27275
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC16 MUC5B MUC12 MUC13 SPON2 MUC3A MUC4 MUC6 MUC20

2.01e-071111109M27416
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC16 MUC5B MUC12 MUC13 NFATC1 MUC3A MUC4 MUC6 MUC20

1.44e-061401109M27484
PathwayREACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS

MUC16 MUC5B MUC13 MUC4 MUC6 MUC20

7.00e-06601106MM15636
PathwayREACTOME_O_LINKED_GLYCOSYLATION

MUC16 MUC5B MUC13 SPON2 MUC4 MUC6 MUC20

2.25e-051091107MM15164
PathwayREACTOME_DISEASES_OF_METABOLISM

MUC16 MUC5B MUC12 MUC13 SPON2 MUC3A MUC4 AGRN MUC6 MUC20

2.55e-0525011010M27554
PathwayWP_MESODERMAL_COMMITMENT_PATHWAY

TRERF1 TBX3 RARB KLF4 NFE2L2 KDM6A HTT

1.93e-041531107M39546
PathwayREACTOME_RND3_GTPASE_CYCLE

MUC13 EPHA2 NISCH SCRIB

3.13e-04421104M41826
PathwayREACTOME_RND3_GTPASE_CYCLE

MUC13 EPHA2 NISCH SCRIB

3.13e-04421104MM15677
PathwayREACTOME_RND2_GTPASE_CYCLE

MUC13 EPHA2 NISCH SCRIB

3.43e-04431104M41827
PathwayREACTOME_RND2_GTPASE_CYCLE

MUC13 EPHA2 NISCH SCRIB

3.75e-04441104MM15678
PathwayREACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3

RALGAPA1 DOCK4 RGPD2 MUC13 TRAK1 EPHA2 NISCH SGO2 SCRIB ARHGAP27 PEAK1 ARHGAP20 SPEN PHIP

5.14e-0464911014MM15690
PathwayREACTOME_RHO_GTPASE_CYCLE

RALGAPA1 DOCK4 MUC13 EPHA2 NISCH SCRIB ARHGAP27 PEAK1 ARHGAP20 SPEN PHIP

6.29e-0443911011MM15595
PathwayPID_P53_DOWNSTREAM_PATHWAY

APC COP1 COL18A1 IGFBP3 EPHA2 HTT

7.07e-041371106M145
PathwayREACTOME_RHO_GTPASE_CYCLE

RALGAPA1 DOCK4 MUC13 EPHA2 NISCH SCRIB ARHGAP27 PEAK1 ARHGAP20 SPEN PHIP

7.71e-0445011011M27078
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ZXDC PALD1 FRAS1 RAPGEF6 CHD8 IRS1 ICE1 CEP192 PPP6R1 HUWE1 BCL9 SRCAP KLF4 ZBTB42 BIRC6 LDLR TRAK1 TBC1D16 CCDC88C TNRC18 AATK RPAP1 NFATC1 NBEAL2 NISCH MBD5 ZNF839 SPEN AGRN SOWAHB RAI1 HTT CD276

2.83e-1711051663335748872
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

9.55e-1518166818834073
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RALGAPA1 DOCK4 RAPGEF6 HIVEP1 MARK3 APC MPDZ IRS1 CEP192 RFX7 TRAK1 CCDC88C MAP7D1 MAST4 ALMS1 STARD9 CCSER2 HELZ SCRIB USP54 PEAK1 MARK2 SRRM2 SAMD4A MAP3K2

5.58e-138611662536931259
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DOCK4 PALD1 FRAS1 MARK3 CEP192 PPP6R1 DCAF5 TRAK1 MAP7D1 RPAP1 STARD9 ZNF451 NISCH ANKRD12 SCRIB SRRM2 SPEN

1.41e-114071661712693553
Pubmed

Interaction network of human early embryonic transcription factors.

TRERF1 TBX3 ZNF609 HIVEP1 CHD8 BCL9 RFX7 UBN2 SIRT1 TNRC18 ALMS1 ELF2 SPEN KDM6A ZHX1 RAI1

1.58e-113511661638297188
Pubmed

Human transcription factor protein interaction networks.

TRERF1 ZNF609 HIVEP1 COP1 CHD8 CEP192 PPP6R1 BCL9 SRCAP RFX7 KLF4 UBN2 INO80D DCAF5 SIRT1 STAT4 MAP7D1 BRD8 ALMS1 NFIX ZNF451 UBXN7 HELZ ELF2 USP54 SRRM2 SPEN KDM6A ZHX1

4.23e-1114291662935140242
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

RALGAPA1 RAPGEF6 MARK1 MARK3 APC MPDZ CEP192 PPP6R1 BIRC6 CCDC88C ALMS1 CCSER2 HELZ USP54 MARK2 SAMD4A MAP3K2

5.87e-114461661724255178
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

TRERF1 RGPD2 ZNF609 RAPGEF6 HIVEP1 APC CHD8 ICE1 ZDBF2 PPP6R1 HUWE1 BIRC6 MAP7D1 TOX4 ALMS1 TACC3

2.08e-104181661634709266
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

RAPGEF6 APC MPDZ ZDBF2 CEP192 PPP6R1 TRAK1 MAST4 ALMS1 EPHA2 SCRIB PEAK1

4.37e-102091661236779422
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

TRERF1 ZNF609 HIVEP1 CHD8 BCL9 KLF4 UBN2 TNRC18 BRD8 NFIX ELF2 KDM6A RAI1

6.39e-102681661333640491
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TRERF1 RAPGEF6 HIVEP1 XPC HUWE1 BCL9 RFX7 SIRT1 BRD8 RPAP1 AFF1 HELZ ELF2 SCRIB MARK2 TACC3 SRRM2 SPEN KDM6A ZHX1

1.05e-097741662015302935
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

SHANK1 TRERF1 RGPD2 HCN4 PRR36 SPTBN2 APC MPDZ CHD8 PPP6R1 HUWE1 BCL9 UBN2 CACNG2 CCDC88C MAP7D1 PTPRN2 NISCH SCRIB TACC3 AGRN RAI1

1.41e-099631662228671696
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

RALGAPA1 ZNF609 MARK3 FAM53A MYT1 CEP192 HUWE1 PPM1K TARS2 UBN2 SHROOM2 CCDC57 BRWD3 TASOR2 COL18A1 TNRC18 NFATC1 PTPRN2 NFIX SETBP1 AFF1 ANKRD12 MBD5 ZNF839 KDM6A RAI1 HTT

2.48e-0914891662728611215
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

RAPGEF6 SPTBN2 MPDZ CHD8 HUWE1 SRCAP UBN2 TOX4 BRD8 ALMS1 SCRIB PEAK1 TACC3 SPEN KDM6A HTT

1.02e-085491661638280479
Pubmed

A human MAP kinase interactome.

SHANK1 TBX3 HIVEP1 SPTBN2 APC CHD8 MUC12 TOX4 ZNF451 HELZ MBD5 ZNF839 MAP2K5 ZHX1 MAP3K2

1.42e-084861661520936779
Pubmed

A census of human transcription factors: function, expression and evolution.

TRERF1 TBX3 HIVEP1 RARB MYT1 ESRRG RFX7 KLF4 STAT4 FOXB1 TOX4 NFATC1 NFE2L2 NFIX ZNF451 SETBP1 HEY2 ELF2 PAX3 ZHX1

1.54e-089081662019274049
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

TBX3 FRAS1 ZNF609 RAPGEF6 APC MPDZ CHD8 PPP6R1 TARS2 PHKA2 MAP7D1 RPAP1 NISCH HELZ SCRIB MARK2 AGRN

1.70e-086501661738777146
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

DOCK4 HIVEP1 APC ZDBF2 CEP192 PPP6R1 HUWE1 ZCCHC2 SRCAP UBN2 SIRT1 ALMS1 NFATC1 ZNF451 HELZ SPEN

2.65e-085881661638580884
Pubmed

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

MARK1 MARK3 APC IRS1 MARK2 SRRM2 SAMD4A MAP3K2

3.41e-08102166815778465
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ZNF609 SPTBN2 HUWE1 SRCAP MAST4 ALMS1 PTPRN2 SRRM2

3.97e-0810416689205841
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

TRERF1 ZXDC TBX3 ZNF609 HIVEP1 MYT1 ESRRG SRCAP KLF4 STAT4 ZBTB37 TOX4 BRD8 NFATC1 NFE2L2 ZNF451 ELF2 KDM6A

7.15e-088081661820412781
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

TBX3 ZNF609 CHD8 XPC PPP6R1 SRCAP PLEKHN1 INO80D LDLR DCAF5 BRWD3 SIRT1 MAP7D1 BRD8 ALMS1 HELZ SCRIB USP54 SRRM2 PHIP RAI1

9.50e-0811161662131753913
Pubmed

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.

MUC16 MUC4 MUC20

1.07e-073166330236127
Pubmed

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.

MUC16 MUC12 MUC20

1.07e-073166326770020
Pubmed

Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation.

EPHB3 APC HUWE1

4.26e-074166327184401
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

RALGAPA1 ZNF609 SPTBN2 GPRIN3 CEP192 PPP6R1 HUWE1 PPM1K TARS2 BIRC6 TOX4 PTPRN2 CD44 HELZ RELL1 SCRIB PEAK1 SRRM2 KDM6A

7.20e-0710491661927880917
Pubmed

Control of sinus venous valve and sinoatrial node development by endocardial NOTCH1.

TBX3 HCN4 NFATC1 HEY2

8.71e-0716166431591643
Pubmed

Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

MUC13 MUC4 MUC20

1.06e-065166317058067
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

TRERF1 TBX3 ZNF609 CHD8 ZDBF2 PPP6R1 TNRC18 BRD8 SGO2 SPEN

1.15e-062821661023667531
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

RAPGEF6 MARK1 APC CEP192 HUWE1 ZCCHC2 SRCAP KLF4 UBN2 SHROOM2 LDLR DCAF5 COL18A1 BRD8 CCSER2 AFF1 ANKRD12 PEAK1 AGRN

1.17e-0610841661911544199
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

TRERF1 ZNF609 RAPGEF6 BCL9 TASOR2 TNRC18 AATK NFE2L2 SETBP1 AFF1 SPEN ZHX1

1.20e-064301661235044719
Pubmed

Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.

MARK1 MARK3 MARK2

2.11e-066166323666762
Pubmed

Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.

MUC16 MUC5B MUC6

2.11e-066166319110483
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

RGPD2 ZNF609 ANPEP APC XPC CEP192 SIRT1 TASOR2 PHKA2 MAP7D1 TOX4 BRD8 MICALL2 ZNF451 CCSER2 SGO2 SCRIB MARK2 TACC3

2.95e-0611551661920360068
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SHANK1 RARB OXR1 DSCR4 SPTBN2 APBA1 APC XPC HUWE1 SHROOM2 DCAF5 BRWD3 RNF123 NFE2L2 ZNF451 NISCH SCRIB USP54 MERTK KDM6A

3.65e-0612851662035914814
Pubmed

Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice.

APC KLF4 HTT

3.69e-067166324204315
Pubmed

PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.

COP1 DCAF5 BRWD3 UBXN7 PHIP

3.75e-0649166531973889
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

TBX3 ZNF609 XPC SRCAP RFX7 KLF4 UBN2 INO80D LDLR MAP7D1 TOX4 BRD8 NFE2L2 NFIX ELF2 SRRM2 SPEN KDM6A RAI1 SAMD4A

4.05e-0612941662030804502
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MARK1 SPTBN2 GPRIN3 ZCCHC2 UBN2 BIRC6 CCDC88C TNRC18 TOX4 ALMS1 PEAK1 MBD5

4.89e-064931661215368895
Pubmed

Functional proteomics mapping of a human signaling pathway.

HIVEP1 RARB XPC HUWE1 TRAK1 PHKA2 RNF123 TOX4 MAST4 ZNF451 AFF1 MERTK KDM6A

5.83e-065911661315231748
Pubmed

Gradual differentiation and confinement of the cardiac conduction system as indicated by marker gene expression.

EPHB3 TBX3 HCN4

5.88e-068166331306714
Pubmed

Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions.

MARK1 MARK3 MARK2

5.88e-068166322298430
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

HIVEP1 CHD8 XPC SRCAP UBN2 SIRT1 ZNF451 SGO2 ELF2 SPEN ZHX1 PHIP RAI1

7.89e-066081661336089195
Pubmed

Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer.

APC NFATC1 CD276

8.78e-069166335364006
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

RALGAPA1 FRAS1 MARK3 SPTBN2 MPDZ CEP192 PPP6R1 TARS2 DCAF5 SIRT1 COL18A1 RPAP1 EPHA2 ZNF451 NISCH CCSER2 RELL1 SCRIB PEAK1 MARK2 SRRM2

9.10e-0614871662133957083
Pubmed

The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.

RALGAPA1 PPP6R1 HUWE1 RFX7 AFF1 SCRIB

1.24e-05106166631024071
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

RALGAPA1 PALD1 ZNF609 APC MPDZ ICE1 ZDBF2 HUWE1 BIRC6 ALMS1 PROSER3 ZNF451 HELZ USP54

1.25e-057331661434672954
Pubmed

Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC.

CD248 RNF19B GPRIN3 CHD8 ICE1 MUC12 SPON2 SCRIB MUC6

1.26e-05293166931741433
Pubmed

Impact of cytosine methylation on DNA binding specificities of human transcription factors.

TBX3 RARB ESRRG RFX7 KLF4 ZBTB37 FOXB1 NFATC1 NFIX HEY2 ELF2 PAX3

1.31e-055441661228473536
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

XPC HUWE1 SRCAP UBN2 F5 BRD8 ALMS1 SGO2 ELF2 SCRIB SPEN PHIP RAI1

1.47e-056451661325281560
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ZNF609 HIVEP1 CHD8 ICE1 ZDBF2 UBN2 TASOR2 TOX4 BRD8 ZNF451 SGO2 ELF2 SRRM2 SPEN PHIP RAI1

1.48e-059541661636373674
Pubmed

Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.

RGPD2 HIVEP1 KCND2

1.71e-0511166322488850
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

HIVEP1 SHROOM2 MAP7D1 ALMS1 NFE2L2 STARD9 SRRM2 MAP2K5

1.75e-05233166837704626
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

RALGAPA1 MARK3 SPTBN2 PLEKHN1 EPHA2 NBEAL2 CD44 RELL1 SCRIB PEAK1 MARK2 CD276

2.04e-055691661230639242
Pubmed

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

ZXDC SH2D3C GPR78 MUC13 ZCCHC2 CPED1 MANSC1 MICALL2 SPON2 NBEAL2 TMEM108 C1QTNF6 ITIH6 SPACA3 CD276 MUC20

2.18e-059851661612975309
Pubmed

MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.

LDLR MERTK

2.26e-052166228067670
Pubmed

Expression of the gut-enriched Krüppel-like factor gene during development and intestinal tumorigenesis.

APC KLF4

2.26e-05216629428642
Pubmed

DCC constrains tumour progression via its dependence receptor activity.

APC DCC

2.26e-052166222158121
Pubmed

SIRT1 exerts protective effects against paraquat-induced injury in mouse type II alveolar epithelial cells by deacetylating NRF2 in vitro.

SIRT1 NFE2L2

2.26e-052166226935021
Pubmed

Role of NRF2 and Sirtuin activators in COVID-19.

SIRT1 NFE2L2

2.26e-052166234798239
Pubmed

STAT4 Regulates the CD8+ Regulatory T Cell/T Follicular Helper Cell Axis and Promotes Atherogenesis in Insulin-Resistant Ldlr-/- Mice.

LDLR STAT4

2.26e-052166229055004
Pubmed

Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice.

LDLR NFE2L2

2.26e-052166226117323
Pubmed

Adenomatous Polyposis Coli Defines Treg Differentiation and Anti-inflammatory Function through Microtubule-Mediated NFAT Localization.

APC NFATC1

2.26e-052166228978472
Pubmed

Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Ldlr-/- mice.

LDLR STAT4

2.26e-052166237396582
Pubmed

Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.

NFE2L2 HTT

2.26e-052166223469253
Pubmed

Extracellular matrix component expression in human pluripotent stem cell-derived retinal organoids recapitulates retinogenesis in vivo and reveals an important role for IMPG1 and CD44 in the development of photoreceptors and interphotoreceptor matrix.

IMPG1 CD44

2.26e-052166229777959
Pubmed

Expression of mucins in mucoid otitis media.

MUC5B MUC4

2.26e-052166214690056
Pubmed

Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.

MUC5B CD44

2.26e-052166218757307
Pubmed

Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.

IGFBP3 CD44

2.26e-052166236766747
Pubmed

Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.

SIRT1 NFE2L2

2.26e-052166229326403
Pubmed

B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/Nrf2 pathway.

NFE2L2 CD276

2.26e-052166237488673
Pubmed

Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.

LDLR SIRT1

2.26e-052166232217100
Pubmed

Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice.

APC LDLR

2.26e-052166211483626
Pubmed

Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.

BRWD3 ARHGAP20

2.26e-052166215543602
Pubmed

Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.

RARB APC

2.26e-052166221680534
Pubmed

Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients.

APC KLF4

2.26e-052166210913614
Pubmed

Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.

APC CD44

2.26e-052166223318432
Pubmed

EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma.

KLF4 EPHA2

2.26e-052166238916835
Pubmed

Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.

SIRT1 NFE2L2

2.26e-052166234403762
Pubmed

Crystal structure of the human Scribble PDZ1 domain bound to the PDZ-binding motif of APC.

APC SCRIB

2.26e-052166230659601
Pubmed

The absence of macrophage Nrf2 promotes early atherogenesis.

LDLR NFE2L2

2.26e-052166223341579
Pubmed

Alzheimer's Amyloid-β Accelerates Cell Senescence and Suppresses the SIRT1/NRF2 Pathway in Human Microglial Cells.

SIRT1 NFE2L2

2.26e-052166236035216
Pubmed

Fasting induces nuclear factor E2-related factor 2 and ATP-binding Cassette transporters via protein kinase A and Sirtuin-1 in mouse and human.

SIRT1 NFE2L2

2.26e-052166223725046
Pubmed

Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis.

APC EPHA2

2.26e-052166219089910
Pubmed

Z-Ligustilide protects vascular endothelial cells from oxidative stress and rescues high fat diet-induced atherosclerosis by activating multiple NRF2 downstream genes.

LDLR NFE2L2

2.26e-052166230897380
Pubmed

Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.

LDLR MERTK

2.26e-052166218467644
Pubmed

Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.

MARK1 MARK2

2.26e-052166216803889
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

2.26e-052166223544943
Pubmed

A steroid like phytochemical Antcin M is an anti-aging reagent that eliminates hyperglycemia-accelerated premature senescence in dermal fibroblasts by direct activation of Nrf2 and SIRT-1.

SIRT1 NFE2L2

2.26e-052166227542238
Pubmed

Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.

MBD5 RAI1

2.26e-052166225853262
Pubmed

Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

MARK3 MARK2

2.26e-052166220733003
Pubmed

Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

LDLR NFE2L2

2.26e-052166223023374
Pubmed

B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway.

SIRT1 CD276

2.26e-052166235029291
Pubmed

Sirtuin 1 Promotes Hyperoxia-Induced Lung Epithelial Cell Death Independent of NF-E2-Related Factor 2 Activation.

SIRT1 NFE2L2

2.26e-052166226465873
Pubmed

Adenomatous Polyposis Coli Modulates Actin and Microtubule Cytoskeleton at the Immunological Synapse to Tune CTL Functions.

APC NFATC1

2.26e-052166232581014
Pubmed

Transcription box‑3 protects human umbilical vein endothelial cells in a high‑glucose environment through sirtuin 1/AKT signaling.

TBX3 SIRT1

2.26e-052166232627000
Pubmed

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

LDLR NFE2L2

2.26e-052166220651288
Pubmed

Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).

RARB APC

2.26e-052166226681652
Pubmed

The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse.

APC CD44

2.26e-052166218085615
Pubmed

DAPLE and MPDZ bind to each other and cooperate to promote apical cell constriction.

MPDZ CCDC88C

2.26e-052166231268831
InteractionTOP3B interactions

ZXDC PALD1 FRAS1 RAPGEF6 SPTBN2 APBA1 CHD8 IRS1 ICE1 CEP192 PPP6R1 HUWE1 BCL9 SRCAP KLF4 ZBTB42 BIRC6 LDLR TRAK1 TBC1D16 CCDC88C TNRC18 AATK RPAP1 NFATC1 NBEAL2 NISCH HELZ MBD5 ZNF839 SPEN AGRN SOWAHB RAI1 HTT CD276

1.53e-09147016336int:TOP3B
InteractionHDAC1 interactions

TRERF1 TBX3 ZNF609 RAPGEF6 HIVEP1 RARB MYT1 APC CHD8 ZDBF2 PPP6R1 KLF4 BIRC6 SIRT1 TRAK1 RNF123 TNRC18 MAP7D1 TOX4 ALMS1 NFATC1 NFE2L2 NFIX HEY2 AFF1 PAX3 TACC3 SPEN ZHX1 RAI1

4.77e-09110816330int:HDAC1
InteractionSFN interactions

RALGAPA1 RAPGEF6 MARK1 MARK3 APC COP1 IRS1 CEP192 TRAK1 CCDC88C MAP7D1 MAST4 ALMS1 CCSER2 SCRIB USP54 PEAK1 MARK2 SRRM2 MAP2K5 HTT SAMD4A MAP3K2

9.17e-0969216323int:SFN
InteractionYWHAG interactions

RALGAPA1 DOCK4 RAPGEF6 HIVEP1 MARK1 MARK3 SH2D3C APC MPDZ IRS1 CEP192 HUWE1 RFX7 SHROOM2 TRAK1 CCDC88C MAP7D1 MAST4 ALMS1 STARD9 CCSER2 HELZ SCRIB USP54 PEAK1 MARK2 SRRM2 HTT SAMD4A MAP3K2

6.91e-08124816330int:YWHAG
InteractionYWHAB interactions

RALGAPA1 DOCK4 RAPGEF6 HIVEP1 MARK1 MARK3 APC COP1 IRS1 CEP192 RFX7 TRAK1 CCDC88C MAP7D1 MAST4 STARD9 CCSER2 SCRIB USP54 PEAK1 MARK2 MERTK SRRM2 HTT SAMD4A MAP3K2

1.71e-07101416326int:YWHAB
InteractionDIRAS3 interactions

RALGAPA1 MARK3 SPTBN2 RNF19B APC GPRIN3 HUWE1 EPHA2 NISCH RELL1 SCRIB PEAK1 MARK2

2.25e-0726216313int:DIRAS3
InteractionYWHAH interactions

RALGAPA1 DOCK4 RAPGEF6 HIVEP1 MARK1 MARK3 APC MPDZ IRS1 CEP192 HUWE1 RFX7 TRAK1 CCDC88C MAP7D1 MAST4 ALMS1 STARD9 CCSER2 SCRIB USP54 PEAK1 MARK2 SRRM2 HTT SAMD4A MAP3K2

2.38e-07110216327int:YWHAH
InteractionYWHAZ interactions

RALGAPA1 RAPGEF6 HIVEP1 MARK1 MARK3 SPTBN2 SH2D3C APC COP1 IRS1 CEP192 HUWE1 TRAK1 CCDC88C MAP7D1 MAST4 STARD9 NBEAL2 NISCH CCSER2 SCRIB USP54 PEAK1 MARK2 ZNF839 MAP2K5 HTT SAMD4A MAP3K2

7.58e-07131916329int:YWHAZ
InteractionGARRE1 interactions

DOCK4 MARK1 MARK3 CEP192 ALMS1 HELZ USP54 MARK2 PHIP SAMD4A

1.08e-0616716310int:GARRE1
InteractionGSK3A interactions

RAPGEF6 MARK3 APC MPDZ ZDBF2 CEP192 PPP6R1 RFX7 TRAK1 TNRC18 MAST4 ALMS1 SCRIB PEAK1 MARK2 SRRM2

1.20e-0646416316int:GSK3A
InteractionTLE3 interactions

TRERF1 TBX3 ZNF609 HIVEP1 BCL9 UBN2 INO80D FOXB1 TNRC18 BRD8 NFIX HELZ SRRM2 SPEN

2.38e-0637616314int:TLE3
InteractionGOLGA1 interactions

RAPGEF6 APC ZDBF2 CEP192 PPP6R1 BIRC6 RPAP1 ALMS1 CCSER2 PEAK1

2.47e-0618316310int:GOLGA1
InteractionRCOR1 interactions

RAPGEF6 HIVEP1 MYT1 APC CHD8 ICE1 ZDBF2 PPP6R1 HUWE1 KLF4 BIRC6 MAP7D1 TOX4 ALMS1 SPEN PHIP

2.71e-0649416316int:RCOR1
InteractionEN1 interactions

ZNF609 HIVEP1 UBN2 DCAF5 SIRT1 SCRIB SRRM2 KDM6A

3.14e-061101638int:EN1
InteractionNUP43 interactions

ZNF609 HIVEP1 APC CHD8 ICE1 ZDBF2 XPC SRCAP UBN2 TASOR2 BRD8 UBXN7 CCSER2 ELF2 SRRM2 SPEN ZHX1 PHIP

3.28e-0662516318int:NUP43
InteractionPHF21A interactions

RAPGEF6 HIVEP1 APC CHD8 ICE1 ZDBF2 PPP6R1 HUWE1 BIRC6 MAP7D1 TOX4 ALMS1 TACC3

4.56e-0634316313int:PHF21A
InteractionCREB1 interactions

HIVEP1 CHD8 LDLR SIRT1 TOX4 BRD8 NFATC1 NFIX ZNF451 ZHX1 HTT

7.29e-0625416311int:CREB1
InteractionCREBBP interactions

TRERF1 HIVEP1 APC HUWE1 SRCAP KLF4 LDLR STAT4 NFATC1 NFE2L2 ZNF451 NISCH HELZ MARK2 KDM6A ZHX1 HTT

7.56e-0659916317int:CREBBP
InteractionWWTR1 interactions

RAPGEF6 MPDZ CHD8 SRCAP TOX4 ALMS1 NFATC1 PAX3 SCRIB PEAK1 TACC3 KDM6A HTT MAP3K2

8.93e-0642216314int:WWTR1
InteractionCTSG interactions

FRAS1 ELOA2 IRAK2 PPP6R1 F5 LDLR IGFBP3

1.21e-05951637int:CTSG
InteractionOCLN interactions

RALGAPA1 RAPGEF6 ANPEP MARK3 SPTBN2 APC GPRIN3 SIRT1 EPHA2 NISCH CCSER2 SCRIB USP54 PEAK1 MARK2

1.40e-0550016315int:OCLN
InteractionRND3 interactions

RALGAPA1 MARK3 SPTBN2 MUC13 EPHA2 NISCH CD44 RELL1 SCRIB PEAK1 MARK2

1.43e-0527316311int:RND3
InteractionHNF4A interactions

ZNF609 HIVEP1 SRCAP UBN2 SIRT1 BRD8 ZNF451 ELF2 SPEN KDM6A ZHX1

1.54e-0527516311int:HNF4A
InteractionAR interactions

TRERF1 TBX3 ZNF609 HIVEP1 SH2D3C CHD8 HUWE1 DCC BCL9 SRCAP KLF4 UBN2 SIRT1 TNRC18 BRD8 NFIX ZNF451 NISCH ELF2 USP54 KDM6A RAI1

1.69e-0599216322int:AR
InteractionETV4 interactions

ZNF609 COP1 BCL9 NFE2L2 KDM6A HTT

2.01e-05691636int:ETV4
InteractionLYN interactions

EPHB3 MARK3 SPTBN2 SH2D3C APC IRAK2 GPRIN3 CCDC88C RNF123 EPHA2 NISCH RELL1 SCRIB PEAK1 MARK2 SRRM2 PHIP HTT

2.23e-0572016318int:LYN
InteractionGSK3B interactions

RAPGEF6 APBA1 APC MPDZ IRS1 ZDBF2 CEP192 PPP6R1 TRAK1 MAST4 ALMS1 NFATC1 NFE2L2 EPHA2 SCRIB PEAK1 MARK2 ZHX1 RAI1 MAP3K2

2.46e-0586816320int:GSK3B
InteractionYWHAE interactions

RALGAPA1 RAPGEF6 HIVEP1 MARK1 MARK3 APC IRS1 HUWE1 SHROOM2 TRAK1 CCDC88C MAP7D1 MAST4 NISCH CCSER2 USP54 PEAK1 MARK2 MERTK ZNF839 SRRM2 AGRN HTT SAMD4A MAP3K2

2.66e-05125616325int:YWHAE
InteractionPARD3 interactions

RAPGEF6 MARK3 APC MPDZ CCDC88C EPHA2 CCSER2 SCRIB USP54 MARK2 HTT

3.22e-0529816311int:PARD3
InteractionZBTB40 interactions

FOXB1 NFATC1 NFIX ELF2

3.24e-05231634int:ZBTB40
InteractionRND1 interactions

RALGAPA1 MARK3 SPTBN2 MUC13 EPHA2 NISCH CD44 SCRIB PEAK1 MARK2

3.29e-0524616310int:RND1
InteractionFLOT1 interactions

MARK3 SPTBN2 APC MPDZ GPRIN3 STAT4 EPHA2 NISCH ELF2 SCRIB USP54 PEAK1 MARK2 HTT

3.32e-0547516314int:FLOT1
InteractionYWHAQ interactions

RALGAPA1 RAPGEF6 MARK1 MARK3 APC IRS1 CEP192 RFX7 TRAK1 CCDC88C MAP7D1 MAST4 NFATC1 STARD9 CCSER2 SCRIB USP54 PEAK1 MARK2 MERTK HTT SAMD4A MAP3K2

3.49e-05111816323int:YWHAQ
InteractionCRX interactions

TRERF1 ZNF609 BCL9 UBN2 TNRC18 UBXN7 SPEN KDM6A ZHX1 RAI1

4.32e-0525416310int:CRX
InteractionC11orf52 interactions

MARK1 MARK3 SPTBN2 MPDZ GPRIN3 EPHA2 NISCH RELL1 SCRIB PEAK1 MARK2

4.74e-0531116311int:C11orf52
InteractionCAMKV interactions

COL18A1 TNRC18 CD44 AFF1 SRRM2 SPEN AGRN

4.95e-051181637int:CAMKV
InteractionNCOR2 interactions

RARB COP1 BRWD3 SIRT1 NFE2L2 NFIX HELZ SPEN AGRN PHIP

5.97e-0526416310int:NCOR2
InteractionSAMD4B interactions

APC CEP192 ALMS1 CCSER2 HELZ PEAK1 SAMD4A

6.12e-051221637int:SAMD4B
InteractionLHX4 interactions

ZNF609 HIVEP1 BCL9 DCAF5 NFIX ELF2 KDM6A ZHX1

6.30e-051661638int:LHX4
InteractionRHOQ interactions

RALGAPA1 PALD1 MARK3 SPTBN2 GPRIN3 MUC13 EPHA2 NISCH CD44 RELL1 SCRIB PEAK1 MARK2

6.53e-0544216313int:RHOQ
InteractionPAX2 interactions

ZNF609 HIVEP1 BCL9 NFIX KDM6A ZHX1

6.59e-05851636int:PAX2
InteractionEPHB2 interactions

EPHB3 MARK3 SH2D3C GPRIN3 EPHA2 NISCH ELF2 SCRIB PEAK1

6.79e-052161639int:EPHB2
InteractionGSC interactions

TBX3 ZNF609 HIVEP1 BCL9 TNRC18 KDM6A

7.51e-05871636int:GSC
InteractionEGR2 interactions

TRERF1 ZNF609 HIVEP1 BCL9 UBN2 TNRC18 NFATC1 KDM6A

7.76e-051711638int:EGR2
InteractionCLIC6 interactions

OXR1 HUWE1 NFE2L2 NISCH

8.37e-05291634int:CLIC6
InteractionNUAK2 interactions

MARK3 DCAF5 UBXN7 MARK2 SRRM2

8.91e-05561635int:NUAK2
InteractionSOX10 interactions

ZNF609 HIVEP1 BCL9 NFIX PAX3 KDM6A

1.03e-04921636int:SOX10
InteractionCARD8 interactions

CHD8 CEP192 SRCAP USP54 PEAK1

1.24e-04601635int:CARD8
InteractionLATS2 interactions

APC MPDZ CEP192 CCDC88C ALMS1 EPHA2 CD44 USP54 MAP2K5 MAP3K2

1.26e-0428916310int:LATS2
InteractionSOX9 interactions

ZNF609 BCL9 UBN2 NFIX SPEN KDM6A

1.37e-04971636int:SOX9
InteractionKDM5C interactions

SPTBN2 LDLR TOX4 BRD8 UBXN7 KDM6A HTT

1.39e-041391637int:KDM5C
InteractionCDIN1 interactions

ZNF609 UBN2 HELZ USP54

1.58e-04341634int:CDIN1
InteractionHMGA1 interactions

XPC SRCAP UBN2 RNF123 TNRC18 NFATC1 SPEN MAP2K5 AGRN PHIP RAI1 HTT

1.61e-0441916312int:HMGA1
InteractionSIN3B interactions

MYT1 LDLR TASOR2 RNF123 TNRC18 BRD8 ELF2

1.96e-041471637int:SIN3B
InteractionALDOB interactions

HIVEP1 DCC MICALL2 MUC20

1.99e-04361634int:ALDOB
InteractionASF1A interactions

HIVEP1 SPTBN2 CHD8 SRCAP UBN2 TASOR2 ELF2 SPEN RAI1

1.99e-042491639int:ASF1A
InteractionPAX6 interactions

ZNF609 HIVEP1 ESRRG BCL9 SRCAP UBN2 NFIX UBXN7 ELF2 KDM6A ZHX1

2.00e-0436616311int:PAX6
InteractionRAB35 interactions

RALGAPA1 PALD1 MARK1 MARK3 SPTBN2 APC GPRIN3 EPHA2 NISCH RELL1 SCRIB PEAK1 MARK2 HTT

2.40e-0457316314int:RAB35
InteractionDNAJC5 interactions

RALGAPA1 MARK3 SPTBN2 MPDZ RPAP1 EPHA2 NISCH RELL1 SCRIB PEAK1 MARK2

2.64e-0437816311int:DNAJC5
InteractionCAV1 interactions

RALGAPA1 RAPGEF6 MARK3 SPTBN2 APC GPRIN3 IRS1 IGFBP3 EPHA2 NISCH UBXN7 CD44 RELL1 SCRIB PEAK1 MARK2

2.68e-0472416316int:CAV1
InteractionELF2 interactions

EPHB3 HIVEP1 SRCAP LDLR BRD8 NFIX ELF2

2.83e-041561637int:ELF2
InteractionKIFAP3 interactions

SPTBN2 APC MUC13 CCSER2 KIF3C MARK2

3.01e-041121636int:KIFAP3
InteractionASH2L interactions

CHD8 ICE1 SRCAP LDLR NFIX SETBP1 ELF2 KDM6A HTT

3.16e-042651639int:ASH2L
InteractionTBR1 interactions

ZNF609 HIVEP1 BCL9 RNF123 NFIX KDM6A

3.16e-041131636int:TBR1
InteractionMARK1 interactions

MARK1 MARK3 APBA1 EPHA2 MARK2

3.34e-04741635int:MARK1
InteractionELF4 interactions

SRCAP BRD8 NFE2L2 ELF2 KDM6A ZHX1

3.47e-041151636int:ELF4
InteractionGUSBP5 interactions

TBX3 TNRC18 ALMS1 HELZ SPEN

3.56e-04751635int:GUSBP5
InteractionCDK6 interactions

ELOA2 COP1 SIRT1 TRAK1 EPHA2 CD44 ANKRD12 MAP2K5

3.72e-042151638int:CDK6
InteractionAFDN interactions

EPHB3 MARK3 APC CEP192 CCDC88C EPHA2 SCRIB USP54 PEAK1 MARK2

3.92e-0433316310int:AFDN
InteractionMARK2 interactions

MARK1 MARK3 APC HUWE1 MANSC1 EPHA2 CD44 MARK2 HTT

4.03e-042741639int:MARK2
InteractionCSNK1G2 interactions

RNF123 KCNE4 EPHA2 NBEAL2 NISCH SRRM2

4.17e-041191636int:CSNK1G2
InteractionTCAF2 interactions

MANSC1 CD44 TMEM108 RELL1

4.35e-04441634int:TCAF2
InteractionC2CD4B interactions

FRAS1 APC MPDZ ICE1

4.35e-04441634int:C2CD4B
InteractionEYA2 interactions

ZNF609 CEP192 PHKA2 AATK HELZ KDM6A

4.56e-041211636int:EYA2
InteractionETS1 interactions

HIVEP1 COP1 HUWE1 SRCAP UBN2 KDM6A

4.56e-041211636int:ETS1
InteractionSOX2 interactions

TRERF1 TBX3 ZNF609 HIVEP1 MARK1 MARK3 SPTBN2 COP1 CHD8 ZDBF2 PPP6R1 BCL9 UBN2 DCAF5 TNRC18 BRD8 NFIX UBXN7 HELZ SGO2 ELF2 MARK2 SPEN KDM6A

4.77e-04142216324int:SOX2
GeneFamilyCD molecules|Mucins

MUC16 MUC5B MUC12 MUC13 MUC3A MUC4 MUC6 MUC20

2.56e-13211098648
GeneFamilyPDZ domain containing

SHANK1 RAPGEF6 APBA1 MPDZ SHROOM2 MAST4 SCRIB

3.76e-0515210971220
GeneFamilyBlood group antigens|CD molecules|Proteoglycans

CD44 AGRN

7.42e-0471092570
GeneFamilySterile alpha motif domain containing

SHANK1 EPHB3 EPHA2 SAMD4A

1.98e-03881094760
GeneFamilyFibronectin type III domain containing

EPHB3 DCC EPHA2 PTPRQ MERTK

2.84e-031601095555
GeneFamilyFibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors

EPHB3 EPHA2

3.13e-031410921095
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

DOCK4 IRS1 ICE1 BRD8 MAST4 NFE2L2 ZNF451 AFF1 HELZ ELF2 SPEN PHIP

4.82e-0730016512M8702
CoexpressionNABA_ECM_AFFILIATED

MUC16 MUC5B MUC12 MUC13 C1QTNF6 MUC3A MUC4 MUC6 MUC20

1.38e-061701659M5880
CoexpressionCUI_TCF21_TARGETS_2_DN

DOCK4 TBX3 HIVEP1 MARK1 GPRIN3 IRS1 PPM1K KLF4 SHROOM2 INO80D DCAF5 MAST4 HEY2 MERTK MBD5 KDM6A ZHX1 SAMD4A MAP3K2

1.99e-0685416519M1533
CoexpressionCUI_TCF21_TARGETS_2_DN

DOCK4 TBX3 HIVEP1 MARK1 GPRIN3 IRS1 PPM1K KLF4 SHROOM2 INO80D DCAF5 MAST4 HEY2 MERTK MBD5 KDM6A ZHX1 SAMD4A MAP3K2

3.50e-0688816519MM1018
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

DOCK4 PCDHGC4 MARK1 APBA1 IRS1 CEP192 DCC SRCAP PLEKHN1 SHROOM2 TBC1D16 SSC5D AATK ALMS1 NISCH HELZ TMEM108 KIF3C ANKRD12 KDM6A HTT

6.27e-06110216521M2369
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

DOCK4 RAPGEF6 MARK1 MYT1 ESRRG APBA1 APC GPRIN3 DCC RFX7 UBN2 SHROOM2 CACNG2 AATK MAST4 NFIX FAM217B KIF3C ANKRD12 RAI1 MAP3K2

6.63e-06110616521M39071
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

TRERF1 RALGAPA1 ZNF609 RAPGEF6 MARK3 SH2D3C GPRIN3 ICE1 PPP6R1 HUWE1 PPM1K RFX7 BIRC6 INO80D DCAF5 STAT4 CCDC88C MAP7D1 NBEAL2 CCSER2 CD44 HELZ SPEN PHIP MAP3K2

7.30e-06149216525M40023
CoexpressionGSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP

ZXDC RAPGEF6 CHD8 ICE1 BRWD3 UBXN7 HELZ PHIP

1.13e-051671658M365
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

DOCK4 MARK1 APBA1 IRS1 CEP192 DCC SRCAP PLEKHN1 SHROOM2 TBC1D16 SSC5D AATK ALMS1 NISCH HELZ TMEM108 KIF3C ANKRD12 KDM6A HTT

2.83e-05112416520MM1070
CoexpressionHALLMARK_MITOTIC_SPINDLE

DOCK4 RAPGEF6 APC CEP192 SHROOM2 ALMS1 KIF3C ARHGAP27

3.98e-051991658M5893
CoexpressionGSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP

ANPEP RNF19B XPC TRAK1 TNRC18 CD44 ELF2 TACC3

3.98e-051991658M5357
CoexpressionBLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP

EPHB3 TBX3 RNF19B MUC16 IRAK2 PPM1K ZCCHC2 KLF4 ZBTB42 SIRT1 IGFBP3 NFATC1 RELL1 SOWAHB

6.08e-0564416514M34026
CoexpressionNABA_ECM_AFFILIATED

MUC16 MUC5B MUC13 C1QTNF6 MUC4 MUC6 MUC20

6.63e-051581657MM17063
CoexpressionHOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP

PALD1 PLEKHN1 AGRN RAI1

1.41e-04421654M41180
CoexpressionLAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET

RALGAPA1 FRAS1 LDLR TRAK1 COL18A1 NFE2L2 AFF1 MBD5

1.47e-042401658M39236
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HPERIC

PALD1 ANPEP CD248 SH2D3C CPED1 STAT4 COL18A1 KCNE4 NFE2L2 SPON2 EPHA2 CD44 HEY2 PEAK1 AGRN

1.59e-0479516515M39050
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBML5

MARK1 MYT1 ESRRG APC VSTM2B DCC UBN2 CACNG2 AATK PTPRN2 ZHX1

1.85e-0446516511M39066
CoexpressionYAGI_AML_WITH_T_9_11_TRANSLOCATION

IMPG1 PHKA2 ZBTB25 ELF2 SCRIB PHIP

1.86e-041311656M16922
CoexpressionWONG_ADULT_TISSUE_STEM_MODULE

EPHB3 MPDZ ZDBF2 MUC13 KLF4 STAT4 IGSF10 COL18A1 IGFBP3 KCND2 NFIX NBEAL2 MUC4 RAI1

1.98e-0472116514M1999
CoexpressionVERRECCHIA_RESPONSE_TO_TGFB1_C1

EPHB3 IGFBP3 CD44

2.20e-04191653M16026
CoexpressionSCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER

TBX3 APBA1 DCC KLF4 CD44

2.39e-04881655M11288
CoexpressionGAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP

MARK1 APC GPRIN3 CHD8 HUWE1 BRD8 SRRM2

2.44e-041951657M1110
CoexpressionGSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN

RNF19B IRS1 ZCCHC2 LDLR CCSER2 AFF1 AGRN

2.68e-041981657M3267
CoexpressionGSE17721_POLYIC_VS_CPG_24H_BMDC_UP

BCL9 CACNG2 PTPRN2 NFIX AFF1 RELL1 MERTK

2.68e-041981657M3953
CoexpressionGSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP

RAPGEF6 HIVEP1 ICE1 MAST4 RELL1 KDM6A MAP3K2

2.68e-041981657M4247
CoexpressionNABA_MATRISOME

FRAS1 IMPG1 MUC16 MUC5B MUC12 MUC13 IGSF10 COL18A1 IGFBP3 SPON2 C1QTNF6 ITIH6 MUC3A MUC4 AGRN MUC6 MUC20

2.71e-04102616517M5889
CoexpressionKRAS.PROSTATE_UP.V1_DN

SH2D3C MUC16 AATK IGFBP3 MUC4 RAI1

2.76e-041411656M2901
CoexpressionGSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP

ZXDC CD248 PHKA2 FOXB1 ZBTB25 CCSER2 CD44

2.77e-041991657M4521
CoexpressionGSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN

EPHB3 RAPGEF6 MARK1 ZCCHC2 COL18A1 MAST4 AGRN

2.77e-041991657M3445
CoexpressionGSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP

ZNF609 ANPEP CHD8 DCC BCL9 MICALL2 SPON2

2.77e-041991657M7259
CoexpressionGSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP

STAT4 IGFBP3 ALMS1 NISCH CCSER2 CD44 ZNF839

2.77e-041991657M7596
CoexpressionGSE20715_WT_VS_TLR4_KO_LUNG_DN

SPTBN2 APC MUC5B CCDC88C SCRIB MERTK SPEN

2.77e-041991657M4350
CoexpressionGSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP

COP1 CEP192 ZCCHC2 TASOR2 UBXN7 SRRM2 KDM6A

2.77e-041991657M5607
CoexpressionGSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN

BIRC6 RNF123 EPHA2 CD44 SGO2 PEAK1 SRRM2

2.77e-041991657M6964
CoexpressionGSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP

COL18A1 KCNE4 UBXN7 CCSER2 ELF2 MERTK SRRM2

2.85e-042001657M5817
CoexpressionGSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN

RALGAPA1 APBA1 IRAK2 INO80D EPHA2 RELL1 MBD5

2.85e-042001657M8001
CoexpressionGSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN

CHD8 UBN2 DCAF5 TNRC18 MAP7D1 ELF2 PHIP

2.85e-042001657M5851
CoexpressionGSE43955_1H_VS_20H_ACT_CD4_TCELL_UP

APC KLF4 TRAK1 NFE2L2 CD44 AFF1 MERTK

2.85e-042001657M9660
CoexpressionGSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP

OXR1 TBC1D16 PHKA2 TNRC18 AATK TACC3 ZNF839

2.85e-042001657M9847
CoexpressionGSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP

CHD8 ZCCHC2 SRCAP RFX7 CCDC88C CD44 ANKRD12

2.85e-042001657M7500
CoexpressionGSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP

MARK3 INO80D IGFBP3 NFE2L2 SGO2 PAX3 ZNF839

2.85e-042001657M9994
CoexpressionGSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN

PALD1 RNF123 MAP7D1 CCSER2 ELF2 TMEM108 TACC3

2.85e-042001657M7996
CoexpressionGSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP

GPR141 GPRIN3 F5 IGSF10 NFATC1 NBEAL2 MERTK

2.85e-042001657M6514
CoexpressionGSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP

DOCK4 APC UBN2 LDLR CCDC88C NFIX CCSER2

2.85e-042001657M5711
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000

DOCK4 TBX3 FRAS1 HIVEP1 RARB CD248 RNF19B MUC16 MPDZ IRS1 ZDBF2 PPM1K BCL9 KLF4 CPED1 BRWD3 IGFBP3 KCND2 TMEM108 ARHGAP20 KDM6A

1.35e-0683116121gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlasdev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000

DOCK4 HIVEP1 RARB CD248 RNF19B MUC16 IRS1 ZDBF2 PPM1K BCL9 KLF4 BRWD3 TNRC18 IGFBP3 KCND2 AFF1 TMEM108 MERTK ARHGAP20 KDM6A

8.20e-0685816120gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlasdev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000

DOCK4 RARB ANPEP CD248 RNF19B MUC16 IRS1 ZDBF2 PPM1K BCL9 KLF4 IGSF10 TNRC18 IGFBP3 KCND2 AFF1 TMEM108 PEAK1 ARHGAP20

1.03e-0579716119gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

CHD8 VSTM2B PPM1K SRCAP CPED1 BIRC6 TNRC18 KCNE4 MAST4 STARD9 NFIX SPON2 NISCH CD44 ANKRD12 ARHGAP20 KDM6A HTT SAMD4A

1.06e-0579916119gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000

TBX3 FRAS1 RARB CD248 MUC16 MPDZ IRS1 ZDBF2 BCL9 CPED1 TMEM108 ARHGAP20

1.72e-0535416112gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000

OXR1 IRS1 RFX7 BRWD3 TASOR2 TBC1D16 IGFBP3 MICALL2 NFATC1 STARD9 ZNF451 UBXN7 SGO2 KDM6A

1.75e-0547816114gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000

DOCK4 ANPEP CD248 RNF19B MUC16 IRS1 ZDBF2 PPM1K BCL9 KLF4 IGSF10 TNRC18 IGFBP3 KCND2 HEY2 AFF1 TMEM108 MERTK ARHGAP20

2.46e-0584916119gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500

DOCK4 ANPEP CD248 RNF19B MUC16 IRS1 ZDBF2 KLF4 IGFBP3 KCND2 TMEM108 MERTK ARHGAP20

2.67e-0543216113gudmap_dev gonad_e11.5_M_GonMes_Sma_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000

RALGAPA1 RARB MARK1 ESRRG APC BCL9 BIRC6 ZBTB37 UBXN7 ELF2 AGRN

2.73e-0531216111gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

CHD8 VSTM2B PPM1K SRCAP BIRC6 TNRC18 KCNE4 MAST4 KCND2 STARD9 NFIX ZNF451 NISCH ANKRD12 ARHGAP20 KDM6A HTT SAMD4A

3.24e-0579016118gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3

SHANK1 EPHB3 TRERF1 ZXDC PRR36 MARK1 MYT1 RNF19B CHD8 DCC CCDC57 TRAK1 PHKA2 SSC5D RNF123 AATK SETBP1

4.14e-0573016117Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000

DOCK4 HIVEP1 RARB ANPEP CD248 RNF19B MUC16 MPDZ IRS1 ZDBF2 PPM1K BCL9 CPED1 BRWD3 IGFBP3 KCND2 AFF1 ARHGAP20

5.85e-0582716118gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000

TBX3 RARB PRR36 MYT1 APC IRAK2 MPDZ BCL9 BRWD3 SIRT1 SSC5D FOXB1 MAP7D1 NFE2L2 PEAK1 TACC3 ITIH6 MUC4 MUC6 PHIP

6.19e-0598916120Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000

TBX3 OXR1 IRS1 HUWE1 RFX7 KLF4 BRWD3 TASOR2 TBC1D16 IGFBP3 MICALL2 NFATC1 STARD9 ZNF451 UBXN7 SGO2 PAX3 KDM6A

8.29e-0585016118gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000

FRAS1 CD248 MARK1 MUC16 IRS1 CEP192 BCL9 CPED1 IGSF10 IGFBP3 KCND2 NFIX HEY2 SGO2 TMEM108 PEAK1 ARHGAP20

8.91e-0577716117gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500

DOCK4 RARB CD248 MUC16 ZDBF2 PPM1K CPED1 BRWD3 IGFBP3 KCND2 TMEM108 ARHGAP20

9.63e-0542316112gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000

CHD8 PPM1K BIRC6 CD44 ANKRD12 KDM6A

9.68e-05971616gudmap_developingGonad_e18.5_epididymis_1000_k4
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500

RARB IRAK2 MPDZ CPED1 MAP7D1 NFIX PAX3 PEAK1 MERTK ITIH6 MUC4 MUC6 PHIP

1.00e-0449216113Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000

CD248 MUC16 IRS1 ZDBF2 BCL9 IGSF10 HEY2 TMEM108 MERTK ARHGAP20

1.36e-0431116110gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000

TBX3 OXR1 MARK1 FAM53A APC BCL9 KLF4 IGFBP3 MICALL2 NFATC1 NFIX UBXN7 HEY2 PAX3 AGRN SAMD4A

2.55e-0476916116gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlasdev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500

CD248 MUC16 IRS1 KLF4 KCND2 TMEM108

2.58e-041161616gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500
CoexpressionAtlasratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5

TBX3 RARB CD248 CPED1 KCNE4 IGFBP3

2.58e-041161616ratio_EB_vs_SC_500_K5
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000

RALGAPA1 TBX3 RAPGEF6 ESRRG APC HUWE1 BCL9 SRCAP BIRC6 NBEAL2 ZNF451 ELF2 AGRN PHIP SOWAHB MUC20

2.74e-0477416116gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

DOCK4 RNF19B CHD8 HUWE1 PPM1K SRCAP BIRC6 SIRT1 TASOR2 MAST4 ALMS1 KCND2 NISCH CD44 ANKRD12 KDM6A

2.82e-0477616116gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasDevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000

HIVEP1 IRS1 VSTM2B KLF4 NFATC1 KCND2 ZNF451 ANKRD12 ARHGAP20

3.63e-042881619gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlasdev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100

MUC16 KCND2 TMEM108

3.79e-04191613gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500

TBX3 PRR36 MYT1 IRAK2 BCL9 SSC5D FOXB1 NFE2L2 PEAK1 ITIH6 MUC4 MUC6

3.86e-0449216112Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500

CD248 MUC16 IRS1 ZDBF2 TMEM108 ARHGAP20

3.86e-041251616gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4

SHANK1 EPHB3 TRERF1 ZXDC PRR36 MARK1 MYT1 RNF19B CHD8 DCC CCDC57 TRAK1 RNF123 AATK SETBP1

4.00e-0472116115Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000

DOCK4 CHD8 PPM1K BIRC6 SIRT1 KCND2 ANKRD12 KDM6A

4.15e-042331618gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

DOCK4 CHD8 HUWE1 PPM1K SRCAP BIRC6 BRWD3 SIRT1 BRD8 MAST4 KCND2 ZNF451 NISCH ANKRD12 ARHGAP20 KDM6A

4.17e-0480416116gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000

CHD8 PPM1K BIRC6 KCND2 ANKRD12 KDM6A

4.20e-041271616gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000

RARB ESRRG IRAK2 MPDZ CPED1 MAP7D1 NFE2L2 NFIX CCSER2 PAX3 C1QTNF6 PEAK1 MERTK ITIH6 MBD5 MUC4 MUC6 PHIP

5.01e-0498516118Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlasdev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200

DOCK4 RNF19B MUC16 ZDBF2 KLF4 KCND2 TMEM108

5.03e-041831617gudmap_dev gonad_e11.5_F_GonMes_Sma_200
CoexpressionAtlasdev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500

DOCK4 CD248 RNF19B MUC16 IRS1 ZDBF2 KLF4 KCND2 AFF1 TMEM108 ARHGAP20

5.10e-0443616111gudmap_dev gonad_e11.5_F_GonMes_Sma_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1

SHANK1 ZNF609 PRR36 MYT1 CCDC88C SSC5D TOX4 AATK SPEN

5.62e-043061619Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000

RALGAPA1 ESRRG APC HUWE1 SRCAP BIRC6 ZNF451 ELF2 AGRN PHIP

6.00e-0437516110gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000

TBX3 OXR1 MARK1 FAM53A KLF4 IGFBP3 MICALL2 NFATC1 HEY2 PAX3

6.25e-0437716110gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2
CoexpressionAtlasratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3

SHANK1 EPHB3 TBX3 RARB CD248 MYT1 APBA1 DCC CPED1 SSC5D KCNE4 IGFBP3 PTPRN2 NFIX SPON2 SETBP1 PAX3 C1QTNF6 ARHGAP20

6.46e-04109416119ratio_EB_vs_SC_2500_K3
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500

DOCK4 PPM1K BIRC6 KCND2 KDM6A

6.48e-04911615gudmap_developingGonad_e12.5_ovary_k5_500
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000

DOCK4 CHD8 PPM1K BIRC6 KCND2 KDM6A

6.53e-041381616gudmap_developingGonad_e12.5_epididymis_k5_1000
CoexpressionAtlasdev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500

DOCK4 ANPEP CD248 MUC16 IRS1 KLF4 IGFBP3 KCND2 TMEM108 ARHGAP20

7.34e-0438516110gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5

SHANK1 EPHB3 TRERF1 PRR36 MARK1 MYT1 CHD8 ZDBF2 DCC TRAK1 SSC5D AATK ALMS1 SETBP1

7.77e-0468816114Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500

RALGAPA1 TBX3 RAPGEF6 ESRRG APC HUWE1 AGRN PHIP SOWAHB MUC20

8.10e-0439016110gudmap_developingKidney_e15.5_cortic collect duct_500
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RALGAPA1 HUWE1 BIRC6 INO80D LDLR STAT4 TASOR2 ANKRD12 SPEN KDM6A MAP3K2

1.36e-1018816611ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

CD248 MARK1 VSTM2B KCNE4 IGFBP3 SPON2 HEY2 CD276

6.05e-0814116687ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ZXDC KLF4 PLEKHN1 INO80D LDLR RNF123 MAST4 STARD9

3.19e-071751668f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRAS1 HCN4 MYT1 IRS1 MAST4 PTPRN2 AFF1 MUC4

3.63e-071781668fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B PLEKHN1 LDLR EPHA2 USP54 MUC4 RAI1

3.79e-0717916686e965e424eebef50f0202cff75f458be395cfca1
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

RALGAPA1 RAPGEF6 GPRIN3 HUWE1 STAT4 ANKRD12 KDM6A MAP3K2

4.12e-071811668f2315414e714ac86211546a935660c4be6e85f1b
ToppCell343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ANPEP CEP192 BCL9 SSC5D PROSER3 MBD5 ARHGAP20 MAP3K2

4.86e-0718516681b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ANPEP CEP192 BCL9 SSC5D PROSER3 MBD5 ARHGAP20 MAP3K2

4.86e-07185166802cbf492bc40abebaa93a3a208888afae72fbe06
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

OXR1 APC IRS1 BIRC6 BRWD3 ALMS1 CCSER2 ANKRD12

5.07e-07186166803db813598b67b1e08f759758a1c2023396921fa
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PALD1 TBX3 CD248 MARK1 ADARB2-AS1 SHROOM2 COL18A1 STARD9

5.49e-071881668ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 DOCK4 TBX3 CD248 CPED1 SSC5D KCNE4 STARD9

5.49e-07188166832f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

TBX3 FRAS1 HIVEP1 HELZ MBD5 SRRM2 KDM6A PHIP

6.44e-071921668916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RALGAPA1 RAPGEF6 GPRIN3 LDLR STAT4 ANKRD12 KDM6A MAP3K2

6.44e-07192166847646d7e4990be85072987f92bf18d52f8da752e
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

TBX3 FRAS1 HIVEP1 HELZ MBD5 SRRM2 KDM6A PHIP

6.70e-071931668e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellE12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FRAS1 CD248 KLF4 IGFBP3 KCND2 NFIX SPON2 ANKRD12

7.24e-071951668febe746099964b9ea9e75f2efc72c962c01f0421
ToppCelldroplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPHB3 LDLR MAST4 EPHA2 ARHGAP27 MUC4 SOWAHB MUC20

7.53e-07196166822fcfb713f402ebbd43b2822f0fd919cdbfba6e4
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF609 ESRRG RFX7 BIRC6 INO80D AFF1 MBD5 KDM6A

8.44e-07199166894b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellAdult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor

MARK1 SPTBN2 MUC16 MUC5B MUC13 PTPRN2 MUC4

2.80e-0616416676e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRAS1 HCN4 MYT1 IRS1 MAST4 AFF1 MUC4

4.15e-061741667f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 TBX3 CD248 GPRIN3 SSC5D KCNE4 C1QTNF6

4.31e-06175166712f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell(06)_Krt4/13+|World / shred by cell type and Timepoint

MUC13 F5 IGFBP3 EPHA2 CD44 MUC4 SOWAHB

4.82e-06178166746efdf03aa1317bc600138e871509b995e773cce
ToppCellnucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC5B MUC13 PTPRN2 MUC3A MUC4 MUC20

5.00e-061791667859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCellCOVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type

TRERF1 TBX3 CD248 CPED1 COL18A1 KCNE4 STARD9

5.00e-061791667342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC5B MUC13 PTPRN2 MUC3A MUC4 MUC20

5.18e-0618016673dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCellnucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 MUC5B MUC13 PTPRN2 MUC3A MUC4 MUC20

5.18e-061801667668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD248 ESRRG SH2D3C COL18A1 KCNE4 HEY2 AGRN

6.42e-0618616676568358812f0ca4e0161a1a1b29682fbced35c79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 ESRRG SPTBN2 LDLR TRAK1 NFE2L2 SETBP1

6.42e-06186166708632045d499e61dd96ff29a5a9a208afe58dc58
ToppCellAT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

FRAS1 LDLR COL18A1 AATK NBEAL2 MUC3A AGRN

6.65e-061871667f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 TBX3 CD248 CPED1 SSC5D KCNE4 STARD9

6.65e-06187166715d6e158562d7d85af3ceaf955439b379c8fce81
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 TBX3 CD248 CPED1 SSC5D KCNE4 STARD9

6.65e-061871667f62074b631fd45ad299c69d71b09267b04d656ee
ToppCellcellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TRERF1 PALD1 HIVEP1 SRCAP LDLR SETBP1 ZNF839

7.13e-061891667bccb3481ffed597c845fe860da658505316105b5
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 ZNF609 OXR1 ESRRG MAST4 SETBP1 MBD5

7.90e-061921667e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RARB APBA1 DCC MAST4 KCND2 TMEM108 ARHGAP20

8.46e-0619416675f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

GPR141 AATK RPAP1 FAM217B ARHGAP27 MERTK SAMD4A

8.46e-06194166788db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

GPR141 AATK RPAP1 FAM217B ARHGAP27 MERTK SAMD4A

8.46e-061941667a71728202493d4858342ea2756ea281cd0d99a3a
ToppCellhuman_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

TRERF1 GPRIN3 STAT4 CCDC88C FCRL3 NFATC1 CD44

8.46e-061941667997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCellGoblet_1|World / shred by cell class for nasal brushing

ANPEP MUC16 PPM1K KLF4 IGFBP3 MUC4 MUC20

8.74e-061951667d9e4889a2e7b7c97c07c15b043b77837739462e4
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

STAT4 CCDC88C FCRL3 IGFBP3 SPON2 CCSER2 SRRM2

9.35e-061971667836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RNF19B CPED1 IGSF10 NFIX SPON2 ARHGAP20 SAMD4A

9.35e-061971667cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class

MUC16 KLF4 LDLR IGFBP3 EPHA2 MUC4 MUC20

9.66e-061981667e735d82e5151c98b5724c543f8ad633c8ed824d2
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RARB ANPEP ESRRG MUC16 MUC5B PTPRN2 MUC4

9.66e-061981667af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 PALD1 RARB SH2D3C KLF4 STARD9 PEAK1

9.66e-0619816670a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCellBrain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type.

TBX3 CD248 ZCCHC2 CPED1 COL18A1 CD44 MAP3K2

1.03e-052001667fe15fb050852c187f6f17fb4f6172e69fe7d74a4
ToppCellBrain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type.

TBX3 CD248 ZCCHC2 CPED1 COL18A1 CD44 MAP3K2

1.03e-052001667d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHB3 PALD1 RGPD2 RARB LDLRAD2 KIF3C

1.62e-051431666d0ed8c25da1327085e042c2e03cb7503e2c52ce0
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHB3 PALD1 RGPD2 RARB LDLRAD2 KIF3C

1.62e-0514316668900b92a24289204b9ec7baccc11594fec7694f1
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

IMPG1 PLEKHN1 SGO2 C1QTNF6 CD276

1.86e-058716658ca87e4a332ef6f035b13e80dcc0110f32172c9a
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE-P3|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

IMPG1 PLEKHN1 SGO2 C1QTNF6 CD276

1.86e-058716654ec3a9489981ed69061c1ca363271edf6a3635d2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHB3 DOCK4 IRAK2 ZNF295-AS1 MICALL2 AGRN

1.97e-051481666fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ANPEP BRWD3 TBC1D16 PHKA2 SPON2 MUC4

2.38e-051531666e7d20c88466ff81db613869cf7a6a4bb95fd6c2f
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBX3 ANPEP CD248 CPED1 KCNE4 SPON2

2.56e-051551666ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBX3 ANPEP CD248 CPED1 KCNE4 SPON2

2.56e-0515516660f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBX3 ANPEP CD248 CPED1 KCNE4 SPON2

2.56e-051551666d8b5145258f075b15080f8739f537f48dd22225e
ToppCellVE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster

ZXDC F5 FCRL3 MAST4 ELF2 ZNF839

2.65e-0515616666501baf73616e702946de9fb13d267e30a68888b
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

RALGAPA1 RAPGEF6 GPRIN3 STAT4 ANKRD12 KDM6A

2.65e-0515616661545169694f686d28648a68b552c2ae606599d66
ToppCellfacs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPDZ CACNG2 ZNF451 SGO2 SAMD4A MUC20

2.75e-051571666370f44047ef438b8f1124c2c2761c150c0d8c57f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 ESRRG ADGRG4 TRAK1 FOXB1 NFE2L2

2.85e-0515816667960337d87afecf2692ab65e5991f052ceddfacc
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPATA3 FRAS1 ESRRG MUC5B DCC PTPRQ

3.06e-051601666c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPATA3 FRAS1 ESRRG MUC5B DCC PTPRQ

3.06e-05160166625c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TBX3 CD248 DCC SSC5D KCNE4 STARD9

3.51e-051641666f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCelldroplet-Heart-HEART-1m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK4 PLEKHN1 ZBTB42 ZBTB37 MICALL2

3.83e-0510116656c4524be89cf3eb06769c2963dcded3da1e71ca0
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GPR141 AATK RPAP1 ARHGAP27 MERTK SAMD4A

4.15e-051691666665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GPR141 AATK RPAP1 ARHGAP27 MERTK SAMD4A

4.15e-0516916666614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 TBX3 DCC CPED1 STAT4 KCNE4

4.29e-051701666876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 TBX3 DCC CPED1 STAT4 KCNE4

4.29e-0517016661f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RALGAPA1 RAPGEF6 GPRIN3 LDLR STAT4 ANKRD12

4.43e-0517116662e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TBX3 CD248 DCC CPED1 KCNE4 STARD9

4.58e-05172166608a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCellMS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster

RGPD2 PLEKHN1 SIRT1 TASOR2 IGFBP3 USP54

4.58e-0517216660b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TBX3 CD248 DCC CPED1 KCNE4 STARD9

4.58e-051721666553701349444eb366df3c11f54bb093434f153c6
ToppCell390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LDLR ZBTB37 COL18A1 RNF123 TNRC18 RELL1

4.58e-05172166684d16cd7f618c94888920680bdc9e7130d73fd75
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

PRR36 SPTBN2 MUC16 MUC5B MUC4 MUC20

4.73e-051731666d1e47c87bd4750801f3531f66a56c5dccb4ea64c
ToppCell356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX3 MARK1 GPR78 SSC5D KCNE4 C1QTNF6

4.73e-05173166675e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells)

TBX3 MARK1 GPR78 SSC5D KCNE4 C1QTNF6

4.73e-05173166626e2e674f5d312fa8f61c11b553dc6101f063b16
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 LDLR MICALL2 EPHA2 MUC3A MUC4

4.88e-051741666207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCellCOVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRERF1 TBX3 DCC COL18A1 KCNE4 SETBP1

4.88e-0517416668393f0b43c767839c1630bcb952d62b42efc788d
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRERF1 CD248 DCAF5 RNF123 MBD5 SAMD4A

5.04e-0517516661d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9

TRERF1 RNF19B NFE2L2 EPHA2 MARK2 SOWAHB

5.04e-0517516660cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPHB3 PRR36 MUC5B MUC12 SCRIB MUC4

5.04e-051751666019ea30ac55748463d7917abf3d3f0e804189bfd
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRERF1 CD248 DCAF5 RNF123 MBD5 SAMD4A

5.04e-051751666427a7ee92fe16a90625946492062d37aa0f7235b
ToppCellwk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SPTBN2 MUC16 HEY2 USP54 MUC4 MUC20

5.20e-0517616668d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

TRERF1 IRAK2 CCDC88C ALMS1 MICALL2 UBXN7

5.37e-051771666eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCellmyeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass

PALD1 PPM1K IGFBP3 SPON2 EPHA2 SETBP1

5.54e-051781666f75591988bbbeba073b66329a3437cb9b02f7648
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPHB3 PRR36 MUC5B MUC12 SCRIB MUC4

5.54e-0517816669099b47e0756d6a1b7ba1c6aa7b47c5425f649e0
ToppCell343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells)

GPRIN3 MUC12 UBN2 INO80D PHKA2 MANSC1

5.54e-0517816665289ac61637224ae70ffbc2d164d73116f10af40
ToppCellT_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

IRS1 PPM1K ZCCHC2 PLEKHN1 IGFBP3 AFF1

5.71e-051791666af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANPEP ZDBF2 IGFBP3 KCND2 PTPRQ TMEM108

5.71e-051791666adf8b025032a03dbb58871a92025cd7efbeb22ff
ToppCellCOPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

PALD1 HIVEP1 PPM1K SPON2 SETBP1 RELL1

5.71e-05179166629b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRR36 MYT1 CCDC57 PTPRQ MUC20

5.76e-051101665c80d1c3df75648e2c8f6832279c2acca63d76681
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

RALGAPA1 GPRIN3 STAT4 FCRL3 CCSER2 CD44

5.89e-0518016660a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCellCOPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class

RAPGEF6 F5 STAT4 CCDC88C FCRL3 MAST4

5.89e-05180166651a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

RALGAPA1 GPRIN3 STAT4 FCRL3 CCSER2 CD44

5.89e-0518016661c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

RALGAPA1 GPRIN3 STAT4 FCRL3 CCSER2 CD44

5.89e-051801666ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 FRAS1 SPTBN2 TRAK1 CCDC88C AFF1

5.89e-051801666023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCellCOVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRERF1 GPRIN3 STAT4 CCDC88C FCRL3 SPON2

6.08e-0518116668906ee8a7a1616dfe8c3b5c73988416641213629
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBX3 CD248 GPRIN3 SSC5D KCNE4 PEAK1

6.08e-051811666a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MARK3 PHKA2 TOX4 NBEAL2 RELL1 USP54

6.08e-051811666f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBX3 CD248 IRS1 CPED1 SSC5D SPON2

6.08e-051811666d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBX3 CD248 GPRIN3 SSC5D KCNE4 PEAK1

6.08e-051811666526e858a848470b6d2d5248788004d9735ed3add
ToppCellfacs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANPEP IRS1 F5 LDLR COL18A1 SPON2

6.26e-051821666770ce9f3f4538d0181a0181543841bc964c68274
ToppCelldroplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPRIN3 COL18A1 AATK PAX3 SCRIB AGRN

6.26e-0518216666fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
Drugestradiol, USP; Down 200; 0.01uM; PC3; HG-U133A

POM121L2 SHROOM2 LDLR MAST4 SPON2 CD44 AFF1 MAP2K5 AGRN HTT SAMD4A

2.32e-0720016411665_DN
DrugGlipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A

ZNF609 CHD8 SRCAP SHROOM2 TOX4 ALMS1 ZBTB25 MAP2K5 SAMD4A MAP3K2

1.81e-06198164104991_DN
DrugDiclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A

EPHB3 RALGAPA1 ZNF609 RNF19B APC TRAK1 NBEAL2 CD44 MAP2K5 SAMD4A

1.90e-06199164102756_DN
DrugNiclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A

HIVEP1 RNF19B LDLR SIRT1 AATK NFE2L2 SPON2 AFF1 SRRM2

4.51e-0617216491998_UP
Drugcellobiitol

MUC12 MUC13 EPHA2 MUC3A MUC4

6.60e-06371645CID000003871
DrugPrilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A

RNF19B RPAP1 NBEAL2 SETBP1 HELZ MARK2 SRRM2 AGRN HTT

1.19e-0519416494284_DN
Drug(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A

PRR36 SRCAP KLF4 RPAP1 CCSER2 CD44 KIF3C MAP2K5 SAMD4A

1.24e-0519516493523_DN
Drug(cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A

SHANK1 APBA1 MUC5B CPED1 INO80D STAT4 PTPRN2 MAP2K5 HTT

1.30e-0519616493889_UP
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A

MPDZ PPP6R1 BCL9 TRAK1 RNF123 RPAP1 ALMS1 MAP2K5 AGRN

1.30e-0519616493248_DN
DrugLasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A

TBX3 ELOA2 HCN4 POM121L2 MUC5B INO80D LDLR SPON2 AFF1

1.30e-0519616493360_UP
DrugDimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A

APBA1 MPDZ DCC BCL9 KLF4 F5 NFATC1 SETBP1 SAMD4A

1.30e-0519616493029_UP
Drugfludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A

ZXDC LDLR TRAK1 PHKA2 NBEAL2 CD44 MARK2 MERTK MAP3K2

1.35e-051971649281_UP
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A

ZNF609 ELOA2 APC SRCAP MAST4 ZBTB25 KIF3C SRRM2 MAP2K5

1.35e-0519716493195_DN
DrugAC1L9LT0

APBA1 APC MPDZ CACNG2 NFE2L2 SCRIB AGRN

3.12e-051231647CID000448294
DrugCycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A

EPHB3 ZXDC RNF19B SRCAP IGFBP3 EPHA2 KDM6A SAMD4A

3.77e-0517316483464_UP
DrugSuccimer

PALD1 HIVEP1 ANPEP RNF19B IRAK2 ZCCHC2 RFX7 KLF4 COL18A1 BRD8 IGFBP3 MICALL2 NFE2L2 STARD9 NFIX CD44 HELZ KIF3C ANKRD12 PHIP MAP3K2 CD276 MUC20

3.93e-05126416423ctd:D004113
DrugNorcyclobenzaprine [303-50-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A

SPTBN2 MUC5B KLF4 LDLR NFIX EPHA2 CD44 KIF3C

5.00e-0518016484776_UP
DrugPodophyllotoxin [518-28-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A

ZNF609 HCN4 RNF19B LDLR CCSER2 CD44 MAP2K5 SAMD4A

5.62e-0518316487198_UP
Drug0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A

EPHB3 ELOA2 RNF19B APC SRCAP F5 CCDC88C SRRM2

5.83e-0518416484755_UP
DrugMagnetite Nanoparticles

PALD1 HIVEP1 ANPEP RNF19B IRAK2 ZCCHC2 RFX7 KLF4 COL18A1 BRD8 IGFBP3 MICALL2 NFE2L2 STARD9 NFIX CD44 HELZ KIF3C ANKRD12 PHIP MAP3K2 CD276 MUC20

6.79e-05131016423ctd:D058185
DrugIsotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A

XPC BCL9 KLF4 ALMS1 MICALL2 CD44 KDM6A SAMD4A

7.58e-0519116487438_DN
DrugBisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A

ZXDC TARS2 SHROOM2 PTPRN2 CCSER2 ZNF839 SRRM2 KDM6A

8.15e-0519316484616_DN
DrugEthamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A

MPDZ RNF123 MAST4 MICALL2 NBEAL2 CCSER2 MAP2K5 AGRN

8.45e-0519416487260_DN
DrugDosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A

ZNF609 APC SRCAP MAST4 RPAP1 ALMS1 HEY2 AGRN

8.45e-0519416482864_DN
DrugLuteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A

ZNF609 RNF19B APC MPDZ INO80D MICALL2 MAP2K5 KDM6A

8.76e-0519516485004_DN
DrugPivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; HL60; HT_HG-U133A

SRCAP TRAK1 CCDC88C MANSC1 PTPRN2 MAP2K5 AGRN HTT

8.76e-0519516482973_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A

ZNF609 ESRRG APC KLF4 INO80D TRAK1 MERTK MAP2K5

9.08e-0519616483762_DN
DrugDipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A

XPC BCL9 TRAK1 TOX4 KIF3C SRRM2 MAP2K5 MAP3K2

9.08e-0519616487124_DN
DrugNorethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

ZNF609 PRR36 RNF19B SRCAP SHROOM2 MANSC1 AGRN HTT

9.08e-0519616481696_DN
DrugNicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A

ZNF609 SRCAP RPAP1 CCSER2 ZNF839 SRRM2 MAP2K5 SAMD4A

9.08e-0519616482058_DN
DrugFK-506; Up 200; 1uM; MCF7; HG-U133A

LDLR TRAK1 PHKA2 MAP7D1 NBEAL2 CD44 MARK2 AGRN

9.41e-051971648284_UP
DrugZimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A

INO80D LDLR SIRT1 PHKA2 TOX4 CD44 ANKRD12 ZNF839

9.41e-0519716482012_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A

RNF19B BCL9 MAP7D1 EPHA2 ZNF839 SRRM2 MAP2K5 AGRN

9.41e-0519716481697_DN
DrugPyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A

EPHB3 APC CCDC88C NFATC1 EPHA2 CCSER2 ANKRD12 SRRM2

9.41e-0519716487171_DN
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A

ZXDC PRR36 RNF19B KLF4 MAST4 EPHA2 MAP2K5 KDM6A

9.41e-0519716481470_DN
DrugMetformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A

PRR36 RNF19B PHKA2 MAST4 ZBTB25 KIF3C MAP2K5 KDM6A

9.74e-0519816481694_DN
DrugHexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A

ZNF609 ELOA2 DSCR4 HUWE1 AATK SPON2 SETBP1 SAMD4A

9.74e-0519816482708_UP
DrugCefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A

RALGAPA1 HCN4 SPTBN2 SRCAP CPED1 F5 KCNE4 MUC4

9.74e-0519816486088_UP
DrugGramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A

EPHB3 TRAK1 PHKA2 RNF123 MAST4 ALMS1 NBEAL2 MARK2

9.74e-0519816482799_DN
DrugJosamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A

ZNF609 PRR36 RNF19B TRAK1 MAST4 RPAP1 MICALL2 CD44

9.74e-0519816481534_DN
DrugDiprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A

ZNF609 RNF19B CCDC88C MAST4 ZBTB25 EPHA2 CD44 MAP2K5

9.74e-0519816481689_DN
DrugTolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A

APC TRAK1 ALMS1 KIF3C ANKRD12 SRRM2 MAP2K5 KDM6A

9.74e-0519816483347_DN
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A

PRR36 APC TRAK1 RNF123 SPON2 KIF3C MAP2K5 KDM6A

9.74e-0519816485433_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A

ELOA2 CD248 HCN4 MUC5B MUC13 INO80D MAST4 CD44

1.01e-0419916483707_UP
DrugTriamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ZXDC HIVEP1 MPDZ RNF123 MAST4 EPHA2 NBEAL2 HTT

1.01e-0419916487192_DN
DrugArtemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

MUC5B TARS2 LDLR NBEAL2 SRRM2 MAP2K5 KDM6A MAP3K2

1.01e-0419916487247_DN
DrugDisopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

EPHB3 ZNF609 MPDZ MAST4 KIF3C SRRM2 MAP2K5 AGRN

1.01e-0419916487439_UP
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A

MPDZ MUC5B SRCAP NBEAL2 TACC3 SRRM2 MAP2K5 KDM6A

1.01e-0419916487254_DN
Drugformononetin

ESRRG SIRT1 NISCH TACC3

1.02e-04341644CID005280378
Drugindomethacin, USP; Up 200; 100uM; MCF7; HG-U133A

LDLR COL18A1 AATK IGFBP3 AFF1 MERTK AGRN SAMD4A

1.04e-042001648453_UP
Diseasevisual impairment and progressive phthisis bulbi (implicated_via_orthology)

MARK1 MARK3 MARK2

6.59e-0741633DOID:0070356 (implicated_via_orthology)
Diseasebody weight

RALGAPA1 HIVEP1 RARB ESRRG POM121L2 CHD8 IRS1 CEP192 HUWE1 DCC MAP7D1 TOX4 KCNE4 AATK MAST4 MICALL2 SETBP1 UBXN7 HEY2 SCRIB ITIH6 MAP2K5

1.87e-06126116322EFO_0004338
DiseaseColorectal Carcinoma

SHANK1 ELOA2 RARB CD248 SPTBN2 APC DCC F5 IGFBP3 RPAP1 NFATC1 PTPRN2 SETBP1 KDM6A PHIP

8.87e-0670216315C0009402
DiseaseProfound Mental Retardation

APC CHD8 DCC COL18A1 SETBP1 PHIP RAI1

1.28e-051391637C0020796
DiseaseMental Retardation, Psychosocial

APC CHD8 DCC COL18A1 SETBP1 PHIP RAI1

1.28e-051391637C0025363
DiseaseMental deficiency

APC CHD8 DCC COL18A1 SETBP1 PHIP RAI1

1.28e-051391637C0917816
DiseaseAutistic Disorder

SHANK1 DOCK4 MARK1 APC COP1 CHD8 XPC IGFBP3 KCND2

1.58e-052611639C0004352
Diseasecholangiocarcinoma (is_marker_for)

MUC16 MUC5B MUC3A MUC4 MUC6

2.83e-05641635DOID:4947 (is_marker_for)
DiseaseACUTE ALCOHOL WITHDRAWAL

ANPEP MPDZ

3.03e-0521632C0149821
DiseaseIntellectual Disability

RALGAPA1 OXR1 APC CHD8 DCC BRWD3 COL18A1 SETBP1 PHIP RAI1 HTT

4.16e-0544716311C3714756
Diseasealcohol and nicotine codependence

RGPD2 HIVEP1 KCND2

4.54e-05131633EFO_0004776
DiseasePolyposis, Adenomatous Intestinal

APC F5 CD44

8.79e-05161633C2713442
DiseaseFamilial Intestinal Polyposis

APC F5 CD44

8.79e-05161633C2713443
DiseaseHydrocephalus

MPDZ CCDC88C

9.07e-0531632cv:C0020255
DiseaseCongenital hydrocephalus

MPDZ CCDC88C

9.07e-0531632cv:C0020256
DiseaseLipidemias

APC IRS1 LDLR

1.06e-04171633C1706412
DiseaseAdenomatous Polyposis Coli

APC F5 CD44

1.06e-04171633C0032580
DiseaseHyperlipidemia

APC IRS1 LDLR

1.06e-04171633C0020473
DiseaseThrombus

KLF4 F5 SIRT1 MERTK

1.22e-04461634C0087086
DiseaseThrombosis

KLF4 F5 SIRT1 MERTK

1.57e-04491634C0040053
Diseasebreast carcinoma

SHANK1 TBX3 CD248 MYT1 ESRRG SPTBN2 POM121L2 CEP192 KLF4 TASOR2 CCDC88C PTPRN2 NFIX SETBP1 ARHGAP27 PHIP

1.76e-04101916316EFO_0000305
Diseasetransitional cell carcinoma (is_implicated_in)

APC IGFBP3 CD44

2.36e-04221633DOID:2671 (is_implicated_in)
Diseasebody surface area

RALGAPA1 HIVEP1 RARB CPED1 MAP7D1 KCNE4 AATK MICALL2 HEY2 SCRIB MAP2K5 SOWAHB

2.53e-0464316312EFO_0022196
Diseasemucinous adenocarcinoma (is_marker_for)

MUC4 MUC6

3.00e-0451632DOID:3030 (is_marker_for)
Diseaseneuroimaging measurement

MARK3 APC DCC CCDC88C COL18A1 MAST4 IGFBP3 PROSER3 NFIX HEY2 AFF1 PAX3 ARHGAP27 TACC3 RAI1 HTT

3.00e-04106916316EFO_0004346
Diseasehydrocephalus (is_implicated_in)

MPDZ CCDC88C

4.48e-0461632DOID:10908 (is_implicated_in)
Diseasewaist-hip ratio

HCN4 DSCR4 FAM53A CEP192 RFX7 CPED1 BIRC6 COL18A1 SSC5D RNF123 MAST4 IGFBP3 NFIX NISCH SETBP1 PHIP HTT

4.66e-04122616317EFO_0004343
Diseaselymphocyte count

PALD1 FRAS1 HIVEP1 PCDHGC4 MARK3 GPRIN3 RFX7 ZNF295-AS1 TBC1D16 TOX4 KCNE4 ALMS1 NFATC1 ZBTB25 NFIX AFF1 HELZ RAI1 HTT

4.85e-04146416319EFO_0004587
Diseaseattention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement

HIVEP1 RARB ESRRG DCC BIRC6 AATK ALMS1 KCND2 PTPRN2 SETBP1 HELZ MAP2K5 CD276

5.32e-0480116313EFO_0003888, EFO_0007052, MONDO_0002491
Diseaseautoantibody measurement

DCAF5 FCRL3

6.25e-0471632EFO_0004866
DiseaseProstatic Neoplasms

TBX3 APC IRS1 SIRT1 IGFBP3 NFE2L2 SPON2 SPEN MUC4 KDM6A CD276

6.61e-0461616311C0033578
DiseaseMalignant neoplasm of prostate

TBX3 APC IRS1 SIRT1 IGFBP3 NFE2L2 SPON2 SPEN MUC4 KDM6A CD276

6.61e-0461616311C0376358
Diseaseprostate cancer (implicated_via_orthology)

APC SIRT1 PAX3

7.99e-04331633DOID:10283 (implicated_via_orthology)
Diseaseblood urea nitrogen measurement

RARB ESRRG GPRIN3 CCDC57 SIRT1 MICALL2 NFATC1 SETBP1 MBD5

9.63e-044521639EFO_0004741
Diseaseresponse to serotonin-norephinephrine reuptake inhibitor

IRAK2 BIRC6 NFATC1

1.03e-03361633EFO_0006325
DiseaseLynch Syndrome

APC CD44

1.06e-0391632C4552100
DiseaseExperimental Autoimmune Encephalomyelitis

SIRT1 NFE2L2

1.06e-0391632C0014072
Diseaseneuroimaging measurement, brain volume measurement

DCC CPED1 CCDC88C MAST4 IGFBP3 PROSER3 HEY2

1.10e-032861637EFO_0004346, EFO_0006930
Diseaseneuroticism measurement, cognitive function measurement

HIVEP1 CD248 ESRRG APC COP1 DCC BIRC6 AATK NFIX RAI1

1.25e-0356616310EFO_0007660, EFO_0008354
DiseaseHereditary Diffuse Gastric Cancer

TBX3 RARB MARK1 APC IGFBP3 CD44 MUC6

1.26e-032931637C1708349
DiseaseSchizophrenia

SHANK1 DOCK4 RAPGEF6 SPTBN2 GPR78 APC DCC BCL9 SIRT1 TRAK1 CACNG2 MARK2 RAI1

1.29e-0388316313C0036341
Diseaseneurodegenerative disease (implicated_via_orthology)

MARK1 MARK3 TRAK1 MARK2 HTT

1.29e-031451635DOID:1289 (implicated_via_orthology)
Diseaseotitis media (is_marker_for)

MUC5B MUC4

1.33e-03101632DOID:10754 (is_marker_for)
DiseaseStomach Neoplasms

TBX3 RARB MARK1 APC IGFBP3 CD44 MUC6

1.37e-032971637C0038356
DiseaseBack pain

FAM53A DCC IGFBP3 SPON2

1.40e-03871634HP_0003418
Diseaseprostate carcinoma

EPHB3 RFX7 KLF4 SHROOM2 ZBTB42 INO80D TASOR2 CCDC88C MAST4 SETBP1 SPEN PHIP SOWAHB

1.40e-0389116313EFO_0001663
Diseasevaline measurement

PPM1K NFATC1 AFF1

1.41e-03401633EFO_0009792
DiseaseMalignant neoplasm of stomach

TBX3 RARB MARK1 APC IGFBP3 CD44 MUC6

1.45e-033001637C0024623
Diseasealcohol consumption measurement

MARK3 ESRRG DCC BIRC6 INO80D ZBTB37 MAST4 ALMS1 KCND2 NFE2L2 SETBP1 ARHGAP27 PEAK1 MAP2K5 AGRN HTT

1.48e-03124216316EFO_0007878
Diseasegait measurement

RARB POM121L2 MANSC1 TACC3 HTT

1.50e-031501635EFO_0007680
DiseaseCarcinoma, Transitional Cell

IGFBP3 TACC3 KDM6A

1.51e-03411633C0007138
DiseaseMacrocephaly

CHD8 BRWD3

1.61e-03111632C0221355
Diseaseunipolar depression, bipolar disorder

COP1 DCC STARD9 SETBP1 MARK2

1.79e-031561635EFO_0003761, MONDO_0004985
DiseaseGastrointestinal Diseases

CHD8 NFE2L2

1.93e-03121632C0017178
DiseaseFunctional Gastrointestinal Disorders

CHD8 NFE2L2

1.93e-03121632C0559031
DiseaseCholera Infantum

CHD8 NFE2L2

1.93e-03121632C1565321
DiseaseThromboembolism

F5 MERTK

1.93e-03121632C0040038
Diseaseesophagus squamous cell carcinoma (is_implicated_in)

DCC SPEN KDM6A

1.98e-03451633DOID:3748 (is_implicated_in)
Diseaseneutrophil percentage of leukocytes

PALD1 HIVEP1 MARK3 SH2D3C KCNE4 AATK NFATC1 HELZ MERTK HTT

2.17e-0361016310EFO_0007990
DiseaseSjogren's Syndrome

STAT4 PHIP

2.27e-03131632C1527336
DiseaseBrugada Syndrome 1

HCN4 HEY2

2.27e-03131632C4551804
DiseaseSicca Syndrome

STAT4 PHIP

2.27e-03131632C0086981
Diseaserestless legs syndrome

MYT1 MICALL2 MAP2K5

2.53e-03491633EFO_0004270
DiseaseAlzheimer disease, educational attainment

RARB APBA1 DCC ZBTB25 NFIX TACC3

2.58e-032471636EFO_0011015, MONDO_0004975
DiseaseHypermetropia

CCDC88C ALMS1 PTPRN2 AGRN

2.60e-031031634HP_0000540
DiseaseMalignant neoplasm of breast

TRERF1 TBX3 RARB SHROOM2 SIRT1 STAT4 FCRL3 NISCH SETBP1 FAM217B HEY2 AFF1 USP54 SPEN

2.62e-03107416314C0006142
Diseaserespiratory quotient

DCC AATK

2.64e-03141632EFO_0005189
Diseasemouth morphology measurement

OXR1 LDLR NFATC1

2.68e-03501633EFO_0007955
Diseasetype 2 diabetes mellitus (implicated_via_orthology)

IRS1 SIRT1 ALMS1 AFF1

2.78e-031051634DOID:9352 (implicated_via_orthology)
DiseaseSquamous cell carcinoma of the head and neck

IRS1 NFE2L2 MERTK

3.00e-03521633C1168401
Diseasehepatocellular carcinoma (is_implicated_in)

APC KLF4 STAT4 NFE2L2 KDM6A

3.40e-031811635DOID:684 (is_implicated_in)
Diseasebrain measurement, neuroimaging measurement

MARK3 DCC CPED1 CCDC88C COL18A1 MAST4 NFIX HEY2 TACC3

3.62e-035501639EFO_0004346, EFO_0004464
Diseasecreatinine measurement

RARB KLF4 BIRC6 LDLR BRWD3 COL18A1 RNF123 ALMS1 MICALL2 NFATC1 NFE2L2 SETBP1 MBD5

3.64e-0399516313EFO_0004518
DiseaseVitiligo

NFE2L2 CD44

3.91e-03171632C0042900
Disease1-Methylhistidine measurement

ALMS1 KCND2

3.91e-03171632EFO_0021543
Diseaseautosomal dominant intellectual developmental disorder (is_implicated_in)

RFX7 SRRM2

3.91e-03171632DOID:0060307 (is_implicated_in)
Diseaselymphocyte percentage of leukocytes

PALD1 HIVEP1 RFX7 ZNF295-AS1 KCNE4 AATK NFATC1 ZBTB25 AFF1 HELZ

4.00e-0366516310EFO_0007993
DiseaseCarcinoma of bladder

PEAK1 KDM6A

4.38e-03181632C0699885
Diseasemean platelet volume

PCDHGC4 IRS1 SRCAP DCAF5 TOX4 BRD8 KCNE4 MAST4 NFATC1 SETBP1 AFF1 PHIP HTT

4.47e-03102016313EFO_0004584
Diseasepancreatic ductal carcinoma (is_marker_for)

MUC5B MUC3A MUC4

4.71e-03611633DOID:3587 (is_marker_for)
DiseaseSystemic Scleroderma

SIRT1 STAT4

4.88e-03191632C0036421
Diseasecleft lip

RARB MUC16 ICE1 CACNG2 SSC5D KCNE4

5.09e-032841636EFO_0003959
Diseasecoagulation factor V measurement

F5 MAST4

5.40e-03201632EFO_0008087
Diseaseseborrheic dermatitis

TNRC18 MAST4

5.40e-03201632EFO_1000764

Protein segments in the cluster

PeptideGeneStartEntry
EAPSPSHSSIIDSTE

COP1

316

Q8NHY2
EVAALSSPASSAPHS

CHD8

426

Q9HCK8
KSPATSPISSNSHRS

BIRC6

576

Q9NR09
PGAVPHTSTETQASR

CPED1

46

A4D0V7
HTLADSIPSSPASSQ

BRD8

681

Q9H0E9
DNIPPASSTHVISTT

ADGRG4

1151

Q8IZF6
TTITANPRTVSHPSS

ADGRG4

2111

Q8IZF6
SLTTTSRSPVSPAHQ

CD248

591

Q9HCU0
EAVAPSTHPTSASVT

AGRN

971

O00468
HTRDVGITFPTPSSS

ALMS1

3901

Q8TCU4
VSHARTSSPFSSPVS

BRWD3

1486

Q6RI45
VLTSHCAPSTPAATR

ADARB2-AS1

51

A8MUL3
VDALASSHPLSTPAS

ANPEP

446

P15144
AHSSVTITPQRSPTG

CD276

231

Q5ZPR3
TPDSDAASPALHSTS

DSCR4

16

P56555
SSEDSCHTTVTTPRP

ANKRD12

1211

Q6UB98
PVPNTTATTHGRSLS

MUC5B

2746

Q9HC84
TVTPSSIPGTTHTAR

MUC5B

4636

Q9HC84
QTFSPSSSHSPARSV

RAI1

336

Q7Z5J4
DRRVTPTCHSSTSEP

PPM1K

31

Q8N3J5
TAEHSPSISPSSVEN

RARB

431

P10826
TSRNSSCDPIVTPHL

GPR141

6

Q7Z602
RPEGPHTSRISSVSS

PTPRN2

681

Q92932
LHRSGTTSQPEAAPT

PALD1

331

Q9ULE6
SRSTEPSHSRDASPV

CACNG2

241

Q9Y698
RLSTTSEVPPAHGSA

HEY2

211

Q9UBP5
TPAETTVTDSHTPGR

MUC16

211

Q8WXI7
SFSPSPDTEVTTISH

MUC16

2251

Q8WXI7
STPATERRTTSTEHP

MUC16

3566

Q8WXI7
LHSTLPVSSEPSTAT

MUC16

4551

Q8WXI7
PESASHSTLPLDTST

MUC16

5276

Q8WXI7
ESVTSSPPNLSSITH

MUC16

5386

Q8WXI7
SRRTSIPGPDHSTES

MUC16

6696

Q8WXI7
TPSESSHSSPLRVTS

MUC16

8871

Q8WXI7
TPTPRETSTSQEIHS

MUC16

9001

Q8WXI7
SHSSPVPVTSLFTSI

MUC16

9456

Q8WXI7
HPEAQTSSAIPTSTI

MUC16

10771

Q8WXI7
SHGAESSSAVPTPTV

MUC16

10856

Q8WXI7
SHGAEASSAVPTPTV

MUC16

11076

Q8WXI7
LVTHPAESSSTLPRT

MUC16

11266

Q8WXI7
VTHPAVTSTTVPRTT

MUC16

11351

Q8WXI7
IHSTSTSPQESPAVS

MUC4

621

Q99102
PLPVTDASSVSTDHA

MUC4

1216

Q99102
STDHATSLPVTIPSA

MUC4

1226

Q99102
HATPLPVTDASSVST

MUC4

1421

Q99102
DHATSLPVTIPSAAS

MUC4

1436

Q99102
TSSVSTAHATPLPVT

MUC4

1766

Q99102
HATPLPVTDASSVST

MUC4

1981

Q99102
PVTDASSVSTGHATP

MUC4

1986

Q99102
PLPVTDASSVSTGHA

MUC4

2256

Q99102
HTTPLPVTDASSAST

MUC4

2381

Q99102
PVTDASSVSTGHATP

MUC4

2866

Q99102
GHATPLPVTDASSVS

MUC4

2876

Q99102
HATPLPVTDTSSAST

MUC4

3661

Q99102
VTDTSSASTRHATPL

MUC4

3891

Q99102
SASTRHATPLPVTDT

MUC4

3896

Q99102
HATPLPVTDTSSAST

MUC4

3901

Q99102
HATPLPVTDTSSVST

MUC4

3981

Q99102
PVAHTTSATSSRLPT

MUC6

1781

Q6W4X9
TSATSSRLPTPFTTH

MUC6

1786

Q6W4X9
VAHTTSASSSRLPTP

MUC6

1951

Q6W4X9
SASSSRLPTPFTTHS

MUC6

1956

Q6W4X9
SPAASTTIRATLPHT

MUC6

2201

Q6W4X9
IAFPSTPRTTASTHT

MUC6

2246

Q6W4X9
TPRTTASTHTAPAFS

MUC6

2251

Q6W4X9
PPTAHLDRTSVSSLS

ELOA2

351

Q8IYF1
SQPEHSSSEEAPSRT

DCC

1316

P43146
NSLTHPPESVAATVS

KLF4

111

O43474
THPGTAASSSPLESR

KCNE4

61

Q8WWG9
TDAHTSRSLTPSPAL

LDLRAD2

226

Q5SZI1
SPRATASALHFPSTS

NFIX

361

Q14938
HLPDGRTATPTSTFT

FRAS1

1396

Q86XX4
APHSLRSDLPTSSDS

IRAK2

161

O43187
PPTEVSIRNSTAHSI

MERTK

286

Q12866
RASESSASSDGPHPV

MUC20

191

Q8N307
HPVITPSRASESSAS

MUC20

241

Q8N307
RASESSASSDGPHPV

MUC20

286

Q8N307
HPVITPSRASESSAS

MUC20

336

Q8N307
RASESSASSDGPHPV

MUC20

381

Q8N307
ISHPPASSDDSRSSA

IMPG1

496

Q17R60
SPTTAPSRSVTHVSL

KIAA1109

1741

Q2LD37
PGPTERSHRSSVSSV

FRMD8P1

11

Q9BZ68
TVPETSRHTGETPNS

KDM6A

726

O15550
LEESNRSSPTHDTPS

CCDC88C

1676

Q9P219
PPSTTHASLASASLR

KIF3C

771

O14782
PAATSATSVHVRSPA

MICALL2

306

Q8IY33
ATSVHVRSPARPSES

MICALL2

311

Q8IY33
HSSPAVSDSLPSNSL

MAP2K5

131

Q13163
SSPPAITSTLHTTAE

MUC3A

1681

Q02505
IATTETPSHSTPRFT

MUC3A

1911

Q02505
PTSPTRSTEAESVLH

PEAK1

896

Q9H792
ISLNTSPSVASPEHS

NFE2L2

346

Q16236
PTADTTTHVTPRNGS

COL18A1

56

P39060
TTHVTPRNGSTEPAT

COL18A1

61

P39060
PTEAPHASASLSLAA

C19orf85

106

A0A1B0GUS0
VPHASSQPRSSLTAV

FAM217B

26

Q9NTX9
RSPVSFSPTDHSLST

MAP3K2

296

Q9Y2U5
HSPSTSPRASVTEES

NFATC1

236

O95644
PTDTPATDSSRAVHG

DCAF5

901

Q96JK2
TDSPSPTVLNSHIST

KCT2

51

Q8NC54
VATVNRPSSHSPSLS

KCND2

506

Q9NZV8
LPATVAVASPHTTSA

MANSC1

226

Q9H8J5
AAPSEVPTLRLHSSS

EPHB3

451

P54753
TASDAGNPPLSTHRT

PCDHGC4

426

Q9Y5F7
SVDGSPVSPSTNRTH

IRS1

341

P35568
TPRPASTHDSSLDVA

GPR78

316

Q96P69
QEPFHPLSSRTVSSS

HELZ

1726

P42694
HAASTTTAPTPAARS

HUWE1

1086

Q7Z6Z7
AHRVQAAASATPTPT

HCN4

756

Q9Y3Q4
ATPSETLTSPASALH

FOXB1

306

Q99853
RVTPPSRTTHSSSTL

PTPRQ

281

Q9UMZ3
SIPQAVSDPSSTVHR

PAX3

316

P23760
HPTEATPSSTFTGIR

OXR1

181

Q8N573
TVPPHRRQTSSTTAF

CCSER2

796

Q9H7U1
SHSSSQVSAVPSDPA

HTT

531

P42858
ILSTSTFPSDPHTAA

IGSF10

976

Q6WRI0
RETTGSSSHASEPTP

ICE1

1306

Q9Y2F5
SSSHASEPTPQAAAL

ICE1

1311

Q9Y2F5
VSSASSSGRPHALPE

C1QTNF6

71

Q9BXI9
QTASPARHTTSVSPS

DOCK4

1796

Q8N1I0
EETPHSTSTIQATPS

CD44

376

P16070
TEPSSPASLTDSVNH

ESRRG

41

P62508
SEPPHGLTRTSVTVS

EPHA2

386

P29317
PRSSTPSHGQTTATE

BCL9

151

O00512
SPHAESQPSVRTSTE

CCDC57

611

Q2TAC2
STSLHPSDPVEASTN

APBA1

416

Q02410
ITSPGHDASSRSPTT

ELF2

361

Q15723
HPVLRASSSTPIEGS

FCRL3

191

Q96P31
TQRVPAASPSAHSIS

MARK1

581

Q9P0L2
AASPSAHSISTATPD

MARK1

586

Q9P0L2
SSAPSPSHKVQRSVS

MARK2

386

Q7KZI7
IPDQRTPVASTHSIS

MARK3

531

P27448
TPVASTHSISSAATP

MARK3

536

P27448
SASPLTPCSVTRSVH

MAP7D1

366

Q3KQU3
SPHSLSSDPSSSRDS

MAST4

1111

O15021
SPSRDSSAASASPHQ

MAST4

1126

O15021
VQHSASTSLSPSPVT

MBD5

426

Q9P267
TNAHASEVDSPPSTR

ITIH6

201

Q6UXX5
QESFRPSTSPLSHSS

CEP192

981

Q8TEP8
SVSLPVEASHIRSPS

INO80D

576

Q53TQ3
THPALTLPVSSDASS

C1orf127

336

Q8N9H9
TPVTAARVVSHSSSP

GPRIN3

201

Q6ZVF9
IRVHSSPVSSPSVSG

SPACA3

11

Q8IXA5
VERSVRPIHSSTSSP

PHKA2

966

P46019
FSSSDPLPATSSHSR

nan

556

A6NNC1
PLPATSSHSRDSAQV

nan

561

A6NNC1
SPSVSSTHRVSDPKF

IGFBP3

151

P17936
SEHSVFTPTETSSPI

ARHGAP20

961

Q9P2F6
PPSSQSDDSTRHITD

TARS2

386

Q9BW92
TSAPESTAPTNHLVA

TACC3

296

Q9Y6A5
DSESPRSTSLHAAAP

RNF19B

6

Q6ZMZ0
DTISVASSLHSSPPA

RAPGEF6

1226

Q8TEU7
TRTSHSLPESSVPST

PLEKHN1

361

Q494U1
PQDTVTEITSSSPSH

SPON2

206

Q9BUD6
QPTKVSRHASSSPES

SRRM2

426

Q9UQ35
APGSHREISSSPTSK

SRRM2

446

Q9UQ35
SQTSPDHRSDTSSPE

SRRM2

1061

Q9UQ35
TSSPEVRQSHSESPS

SRRM2

1071

Q9UQ35
ASPDSRHSPATISSS

TBX3

431

O15119
TSDPSHRSSSPELSE

F5

1141

P12259
PAPTSRFSITHVSDS

AATK

1341

Q6ZMQ8
SSSSVHDSPLASSPV

RGPD2

1256

P0DJD1
HPALTRSQSVPASTG

NBEAL2

751

Q6ZNJ1
SASEHSTTEPSPAAR

PRR36

211

Q9H6K5
ASPATSPASVDSHVS

ARHGAP27

286

Q6ZUM4
SLSSSDVRFPQSPHS

SHROOM2

411

Q13796
PLHVSEDSSSPERTS

SIRT1

531

Q96EB6
SSIVDVPPRESHSHS

SGO2

226

Q562F6
PHTAVPTAVNVTSAS

PROSER3

156

Q2NL68
PESTPQHSSLETTSR

SPATA3

51

Q8NHX4
HSSPPTAAVATTSIT

SCRIB

961

Q14160
RSPESVSRSAHTPSD

STARD9

4321

Q9P2P6
SAHQTRSTTTPPRCS

SRCAP

2416

Q6ZRS2
TPHSALTSEATSDAP

SSC5D

1031

A1L4H1
AHSPPATVEAATSRA

SOWAHB

256

A6NEL2
TSHLSASAPPDATSA

POM121L2

516

Q96KW2
RSSSDHPLETISSAS

SHANK1

1681

Q9Y566
SLPEPVASAHSSSAE

AFF1

456

P51825
IHIPGVRNSSSSTSP

APC

2231

P25054
RLATSTPVQHPETSA

TRAK1

641

Q9UPV9
ESVISQSHPSPSSEV

ZBTB25

211

P24278
SPSPALTHSTAQSDS

ZCCHC2

971

Q9C0B9
PSEARAPHASSLTAA

TNRC18

2071

O15417
PSSAITVIDHSPANS

ZNF451

586

Q9Y4E5
SHPLVSRTVPSTTTS

UBN2

996

Q6ZU65
PHRPSTASGSSVVTA

UBN2

1206

Q6ZU65
HITTPTSSSTPRENA

ZXDC

636

Q2QGD7
PHSISPETTVTSRGQ

ZBTB37

461

Q5TC79
SESASPVHSPLGSRS

RALGAPA1

986

Q6GYQ0
SPSAASTISAHSNPV

MPDZ

236

O75970
FPRASHPSSTASTAL

SPEN

3036

Q96T58
STHSSSTIPIPTAAD

MUC13

91

Q9H3R2
SRGSISSTSEVHSPP

PHIP

671

Q8WWQ0
SSTSEVHSPPNVGLR

PHIP

676

Q8WWQ0
QSRSTESAHAATLPP

SPTBN2

2196

O15020
RIFSSSEHAPPAATS

RNF123

41

Q5XPI4
ISTIRSDSTEPHSPS

STAT4

701

Q14765
PEAAAASAAHTPTTT

VSTM2B

216

A6NLU5
TLHSRTETTPSPSND

RELL1

36

Q8IUW5
TRSSGASHQPSPTEL

TBC1D16

116

Q8TBP0
SSLSSTDSLTPEHQP

NISCH

521

Q9Y2I1
SSEHRPPASSTSEDV

ZNF609

416

O15014
RIHPSTASTVVTPAA

ZHX1

241

Q9UKY1
RNPVPSSHVETTSFS

ZDBF2

236

Q9HCK1
TPVDSALGSSRHTPI

RFX7

891

Q2KHR2
HRASDTPSGLSPTDT

RPAP1

1111

Q9BWH6
ATRDPSTSVPASGAH

PPP6R1

821

Q9UPN7
VSPRSEESHTTTVSG

ZNF839

536

A8K0R7
SEQEESSSSRSPHSP

ZBTB42

231

B2RXF5
TSSASVSTVRPHTEE

UBXN7

61

O94888
TVTRVHAAPAAPSAT

SH2D3C

421

Q8N5H7
VSPAASLRHPVSTSE

TASOR2

1086

Q5VWN6
PSSSSPTVVFQSHRR

ZNF295-AS1

21

Q8N0V1
HRKDPSLPAASSSSS

XPC

491

Q01831
IHEGTSTSPVSPISR

SETBP1

601

Q9Y6X0
SVLSATPSVTASPQH

HIVEP1

2201

P15822
NDTIPSVDTSRSPCH

HIVEP1

2286

P15822
SDHAPLSPQSSVASS

SAMD4A

286

Q9UPU9
DRLSTTPSPTSSLHE

TOX4

171

O94842
PTHPSRVSESTISGA

TMEM108

386

Q6UXF1
RCSSSSSLPVIHDPS

USP54

1451

Q70EL1
PASSDLTRVSSTLPH

TRERF1

436

Q96PN7
SESTGSSTAPPTKRH

FAM53A

106

Q6NSI3
VRTQHTTTRPVPDTS

LDLR

736

P01130
EESTPVHSSPVATAT

MUC12

471

Q9UKN1
STTFHSSPRSPATTL

MUC12

966

Q9UKN1
SEKSTTFHSSPRSPA

MUC12

2046

Q9UKN1
RVHSSTGSPRTTLSP

MUC12

2191

Q9UKN1
VEVSTTYHSRPSSTP

MUC12

3161

Q9UKN1
GRSEESTTVHSSPVA

MUC12

3436

Q9UKN1
STTFHSSPRSPATTL

MUC12

3606

Q9UKN1
KSPDASQRHSSTSAP

MYT1

696

Q01538